1 |
(-)-trans-delta-9-tetrahydrocannabinol |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
2 |
(im) avonex® |
- |
- |
- |
- |
013 1件: 13 💬 |
3 |
(r) 3-(5-dimethylcarbamoyl-pent-1-enyl)-n-(2-hydroxy-1- methylethyl) benzamide |
- |
- |
- |
- |
013 1件: 13 💬 |
4 |
0,5 mg fingolimod |
Fingolimod |
1件: D10001 D10001 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
5 |
0.25 mg rpc1063 |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
6 |
0.25mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
7 |
0.5 mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
8 |
0.5mg rpc1063 |
- |
- |
- |
- |
013 1件: 13 💬 |
9 |
1 - andrographis paniculata p/st extract |
- |
- |
- |
- |
013 1件: 13 💬 |
10 |
1 mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
11 |
1% steroid cream |
- |
- |
- |
- |
013 1件: 13 💬 |
12 |
1-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1h-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone |
- |
- |
- |
- |
013 1件: 13 💬 |
13 |
1.0mg rpc1063 |
- |
- |
- |
- |
013 1件: 13 💬 |
14 |
10 milligram (mg) fampridine-sr (4-aminopyridine, 4-ap) |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
15 |
10000iu vitamin d |
Vitamin D |
- |
- |
- |
013 1件: 13 💬 |
16 |
11c-acetate |
Acetate |
- |
- |
- |
013 3件: 13, 86, 88 💬 |
17 |
11c-pbr28 |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
18 |
11c-pib |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
19 |
13-pcv booster |
- |
- |
- |
- |
013 1件: 13 💬 |
20 |
13-valent pneumococcal conjugate vaccine (13-pcv) |
- |
- |
- |
- |
013 1件: 13 💬 |
21 |
1393641-34-3 |
- |
- |
- |
- |
013 1件: 13 💬 |
22 |
15 mg fampridine-sr (4-aminopyridine, 4-ap) |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
23 |
18f-dpa-714 and 18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
013 1件: 13 💬 |
24 |
18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
005 12件: 5 , 6 , 7 , 13, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
25 |
18f-pm-pbb3 |
- |
- |
- |
- |
013 1件: 13 💬 |
26 |
19 nor vitamin d |
Vitamin D |
- |
- |
- |
013 1件: 13 💬 |
27 |
2 - excipients |
- |
- |
- |
- |
013 1件: 13 💬 |
28 |
2-(2-(2-amino-9h-purin-9-yl)ethyl)-1,3-propanediol diacetate ester |
- |
- |
- |
- |
013 1件: 13 💬 |
29 |
2-cda |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
30 |
2-cda, 2-chloro-2'-deoxy-beta-d-adenosine |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
31 |
2-cda, 2-chloro-2'-deoxy-ß-d-adenosine |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
32 |
2-cda, 2-chloro-2?-deoxy-beta-d-adenosine |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
33 |
2-cda, 2-chloro-2?-deoxy-ß-d-adenosine |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
34 |
2-cda, 2-chloro-2’-deoxy-beta-d-adenosine |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
35 |
2-cda, 2-chloro-2’-deoxy-ß-d-adenosine |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
36 |
2-chloro-2'-deoxy-beta-d-adenosine (2-cda) |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
37 |
2-chloro-2'-deoxy-ß-d-adenosine (2-cda) |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
38 |
2-chloro-2'-deoxyadenosine (2-cda) |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
39 |
2-chloro-2'-deoxyadenosine, 2cda |
- |
- |
- |
- |
013 1件: 13 💬 |
40 |
2-chloro-2?-deoxy-beta-d-adenosine |
Adenosine |
1件: D00045 D00045 💬 |
ADORA1 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
41 |
2-chloro-2?-deoxy-ß-d-adenosine |
Adenosine |
1件: D00045 D00045 💬 |
ADORA1 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
42 |
2-chloro-2’-deoxy-beta-d-adenosine |
Adenosine |
1件: D00045 D00045 💬 |
ADORA1 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
43 |
2-chloro-2’-deoxy-beta-d-adenosine (2-cda) |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
44 |
2-chloro-2’-deoxy-ß-d-adenosine |
Adenosine |
1件: D00045 D00045 💬 |
ADORA1 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
45 |
2-chloro-2’-deoxy-ß-d-adenosine (2-cda) |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
46 |
2-chloro-2’-deoxyadenosine (2-cda) |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
47 |
20 mg fampridine-sr (4-aminopyridine, 4-ap) |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
48 |
20 mg ga |
- |
- |
- |
- |
013 1件: 13 💬 |
49 |
20 mg mitoq |
- |
- |
- |
- |
013 1件: 13 💬 |
50 |
200106 or emd 28162 |
- |
- |
- |
- |
013 1件: 13 💬 |
51 |
20mg/0.5ml ga |
- |
- |
- |
- |
013 1件: 13 💬 |
52 |
20mg/0.5ml glatiramer acetate |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
53 |
23-ppv |
- |
- |
- |
- |
013 1件: 13 💬 |
54 |
23-valent pneumococcal polysaccharide vaccine |
- |
- |
- |
- |
013 3件: 13, 46, 53 💬 |
55 |
23-valent pneumococcal polysaccharide vaccine (23-ppv) |
- |
- |
- |
- |
013 1件: 13 💬 |
56 |
25oh-vitamin d |
Vitamin D |
- |
- |
- |
013 1件: 13 💬 |
57 |
2b3-201 |
- |
- |
- |
- |
013 1件: 13 💬 |
58 |
3 mg melatonin |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
59 |
3,4-diaminopyridine |
- |
- |
- |
- |
011 3件: 11, 12, 13 💬 |
60 |
4-aminopyridine |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 2件: 3 , 13 💬 |
61 |
4-ap |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
62 |
4.5 mg naltrexone |
Naltrexone |
2件: D02095 D02095, D05113 D05113 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
63 |
40 mg ga |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
64 |
40 mg glatiramer acetate |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
002 2件: 2 , 13 💬 |
65 |
40 mg glatiramer acetato |
Glatiramer |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
66 |
40mg of mitoq |
- |
- |
- |
- |
013 1件: 13 💬 |
67 |
5 mg melatonin |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
68 |
5000iu vitamin d |
Vitamin D |
- |
- |
- |
013 1件: 13 💬 |
69 |
52069.00.01 |
- |
- |
- |
- |
013 1件: 13 💬 |
70 |
9060x |
- |
- |
- |
- |
013 2件: 13, 149 💬 |
71 |
95% pure ecgc capsules 200mg |
- |
- |
- |
- |
013 1件: 13 💬 |
72 |
[11c]flumazenil |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
013 1件: 13 💬 |
73 |
[123i]clinde |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
74 |
[14c]-rpc1063 solution (0.1 mg/ml) for oral administration |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
75 |
[18f] pbr06 |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
76 |
[18f]-feppa |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
77 |
[18f]dpa-714 |
- |
- |
- |
- |
013 1件: 13 💬 |
78 |
[18f]florbetapir and pet imaging |
- |
- |
- |
- |
013 1件: 13 💬 |
79 |
[c-11]methylreboxetine |
- |
- |
- |
- |
013 1件: 13 💬 |
80 |
[c-11]pbr28 |
- |
- |
- |
- |
013 1件: 13 💬 |
81 |
[c11]pk-1195 pet scan |
- |
- |
- |
- |
013 1件: 13 💬 |
82 |
[f-18]pbr06 |
- |
- |
- |
- |
013 2件: 13, 17 💬 |
83 |
[f-18]sdm-8 |
- |
- |
- |
- |
013 1件: 13 💬 |
84 |
[formistin 10 mg] |
- |
- |
- |
- |
013 1件: 13 💬 |
85 |
[md1003] |
- |
- |
- |
- |
013 1件: 13 💬 |
86 |
[metilprednisolone] |
- |
- |
- |
- |
013 1件: 13 💬 |
87 |
[omb157] |
- |
- |
- |
- |
013 1件: 13 💬 |
88 |
[tachipirina cpr 500mg] |
- |
- |
- |
- |
013 1件: 13 💬 |
89 |
[zr-89]oxine-labeled leukocytes pet/mr |
Oxyquinoline |
1件: D05321 D05321 💬 |
- |
- |
013 1件: 13 💬 |
90 |
A4i antagonist |
- |
- |
- |
- |
013 1件: 13 💬 |
91 |
Ab1010 |
- |
- |
- |
- |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
92 |
Abatacept |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
93 |
Abobotulinumtoxin a |
- |
- |
- |
- |
013 1件: 13 💬 |
94 |
Abr-215062 |
- |
- |
- |
- |
013 1件: 13 💬 |
95 |
Abr-215062 sodium salt |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
96 |
Abt-555 |
- |
- |
- |
- |
013 1件: 13 💬 |
97 |
Abt-874/human monoclonal antibody against il-12 |
- |
- |
- |
- |
013 1件: 13 💬 |
98 |
Abx-1431 |
ABX-1431 |
- |
- |
- |
013 1件: 13 💬 |
99 |
Abx-1431 hcl |
ABX-1431 |
- |
- |
- |
013 1件: 13 💬 |
100 |
Acetaminophen |
Acetaminophen |
1件: D00217 D00217 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 14件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
101 |
Acetaminophen tab 650mg |
Acetaminophen |
1件: D00217 D00217 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
102 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
103 |
Acetazolamide |
Acetazolamide |
2件: D00218 D00218, D01196 D01196 💬 |
CA1 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 |
Bile secretion 7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation |
013 6件: 13, 90, 115, 155, 225, 230 💬 |
104 |
Acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 16件: 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
105 |
Acetylsalicylic acid |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 4件: 13, 46, 51, 210 💬 |
106 |
Acetylsalicylic acid at 1st visit, |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
107 |
Aciclovir |
Acyclovir |
1件: D00222 D00222 💬 |
- |
- |
013 2件: 13, 60 💬 |
108 |
Aclasta |
- |
- |
- |
- |
013 3件: 13, 271, 274 💬 |
109 |
Aclasta 5 mg infusionslösung |
- |
- |
- |
- |
013 1件: 13 💬 |
110 |
Aclasta 5mg solution for infusion |
- |
- |
- |
- |
013 1件: 13 💬 |
111 |
Act |
- |
- |
- |
- |
013 1件: 13 💬 |
112 |
Act-1 |
- |
- |
- |
- |
013 1件: 13 💬 |
113 |
Act-128800 |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
114 |
Act-128800 dose 1 |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
115 |
Act-128800 dose 2 |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
116 |
Act-128800 dose 3 |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
117 |
Acth |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 5件: 13, 66, 145, 193, 222 💬 |
118 |
Acthar |
- |
- |
- |
- |
002 9件: 2 , 13, 14, 46, 49, 50, 66, 84, 222 💬 |
119 |
Acthar gel |
- |
- |
- |
- |
013 6件: 13, 46, 49, 50, 84, 222 💬 |
120 |
Acthar gel (acth) |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 1件: 13 💬 |
121 |
Active comparator receiving extavia® |
- |
- |
- |
- |
013 1件: 13 💬 |
122 |
Active control |
- |
- |
- |
- |
013 1件: 13 💬 |
123 |
Actos (pioglitazone) |
Pioglitazone |
2件: D00945 D00945, D08378 D08378 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
013 1件: 13 💬 |
124 |
Acyclovir |
Acyclovir |
1件: D00222 D00222 💬 |
- |
- |
013 2件: 13, 28 💬 |
125 |
Adderall xr |
- |
- |
- |
- |
013 1件: 13 💬 |
126 |
Adderall xr 10 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
127 |
Adderall xr 5mg |
- |
- |
- |
- |
013 1件: 13 💬 |
128 |
Adenosine |
Adenosine |
1件: D00045 D00045 💬 |
ADORA1 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 3件: 13, 58, 65 💬 |
129 |
Adrenocorticotropic hormone |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 3件: 13, 50, 84 💬 |
130 |
Adrenocorticotropic hormone (acth) gel (h.p. acthar®) |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 1件: 13 💬 |
131 |
Ads-5102 |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
132 |
Ads-5102, 137 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
133 |
Ads-5102, 274 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
134 |
Aert, (r)-baclofen |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
135 |
Agee cream |
- |
- |
- |
- |
013 1件: 13 💬 |
136 |
Ahsc |
- |
- |
- |
- |
013 1件: 13 💬 |
137 |
Aimspro |
- |
- |
- |
- |
013 2件: 13, 51 💬 |
138 |
Ain |
- |
- |
- |
- |
013 1件: 13 💬 |
139 |
Ain457 |
- |
- |
- |
- |
013 7件: 13, 37, 41, 46, 56, 96, 271 💬 |
140 |
Alanine |
Alanine |
1件: D00012 D00012 💬 |
- |
- |
006 4件: 6 , 13, 298, 299 💬 |
141 |
Albumin (human) 25%, united states pharmacopeia (usp) |
- |
- |
- |
- |
013 2件: 13, 14 💬 |
142 |
Albuterol |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
012 8件: 12, 13, 86, 89, 113, 231, 256, 299 💬 |
143 |
Alcohol |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
013 4件: 13, 58, 279, 298 💬 |
144 |
Alemtuzumab |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 16件: 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
145 |
Alemtuzumab (gz402673) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
146 |
Alemtuzumab 12 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
147 |
Alemtuzumab 24 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
148 |
Alemtuzumab gz402673 |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
149 |
Alemtuzumab immunotherapy |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
150 |
Alemtuzumab injection |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
151 |
Alemtuzumab injection [lemtrada] |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
152 |
Alfuzosin |
Alfuzosin |
2件: D01692 D01692, D07124 D07124 💬 |
ADRA1A 1件: ADRA1A 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
153 |
Alks 8700 |
- |
- |
- |
- |
013 1件: 13 💬 |
154 |
Alks 8700 delayed release (dr) |
- |
- |
- |
- |
013 1件: 13 💬 |
155 |
Alks 8700 delayed release (dr) capsule |
- |
- |
- |
- |
013 1件: 13 💬 |
156 |
Allogeneic fecal microbiota |
- |
- |
- |
- |
013 1件: 13 💬 |
157 |
Allogeneic human umbilical cord tissue-derived mesenchymal stem cells |
- |
- |
- |
- |
013 1件: 13 💬 |
158 |
Alpha lipoic acid |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
013 1件: 13 💬 |
159 |
Alpha-lipoic acid |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
002 2件: 2 , 13 💬 |
160 |
Alpha1-antitrypsin |
- |
- |
- |
- |
013 1件: 13 💬 |
161 |
Altri farmaci del sistema nervoso |
- |
- |
- |
- |
013 1件: 13 💬 |
162 |
Alxn1210 |
- |
- |
- |
- |
002 5件: 2 , 11, 13, 62, 109 💬 |
163 |
Amantadine |
Amantadine |
2件: D00777 D00777, D07441 D07441 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 4件: 6 , 8 , 13, 127 💬 |
164 |
American ginseng |
Ginseng |
1件: D06772 D06772 💬 |
- |
- |
013 1件: 13 💬 |
165 |
American ginseng extract ht-1001 |
Ginseng |
1件: D06772 D06772 💬 |
- |
- |
013 1件: 13 💬 |
166 |
Amiloride |
Amiloride |
2件: D00649 D00649, D07447 D07447 💬 |
SCNN1A 3件: SCNN1A, SCNN1B, SCNN1G 💬 |
Aldosterone-regulated sodium reabsorption 2件: Aldosterone-regulated sodium reabsorption, Taste transduction |
013 3件: 13, 225, 299 💬 |
167 |
Amiloride hydrochloride |
Amiloride |
2件: D00649 D00649, D07447 D07447 💬 |
SCNN1A 3件: SCNN1A, SCNN1B, SCNN1G 💬 |
Aldosterone-regulated sodium reabsorption 2件: Aldosterone-regulated sodium reabsorption, Taste transduction |
013 1件: 13 💬 |
168 |
Amiloride hydrochloride, 2 h2o |
Amiloride |
2件: D00649 D00649, D07447 D07447 💬 |
SCNN1A 3件: SCNN1A, SCNN1B, SCNN1G 💬 |
Aldosterone-regulated sodium reabsorption 2件: Aldosterone-regulated sodium reabsorption, Taste transduction |
013 1件: 13 💬 |
169 |
Amilostad |
- |
- |
- |
- |
013 1件: 13 💬 |
170 |
Amilostad hct |
- |
- |
- |
- |
013 1件: 13 💬 |
171 |
Amilostad hct tablets |
- |
- |
- |
- |
013 1件: 13 💬 |
172 |
Ampyra |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
173 |
Amyvid |
- |
- |
- |
- |
013 2件: 13, 127 💬 |
174 |
Amyvid radiopharmaceutical |
- |
- |
- |
- |
013 1件: 13 💬 |
175 |
An100226 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
176 |
An100226, bg00002 |
- |
- |
- |
- |
013 1件: 13 💬 |
177 |
Anakinra |
Anakinra |
1件: D02934 D02934 💬 |
IL1R1 2件: IL1R1, IL1R2 💬 |
Amoebiasis 15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 17件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬 |
178 |
Androgel 1 % topical gel |
- |
- |
- |
- |
013 1件: 13 💬 |
179 |
Androgel 10 grams of gel containing 100 mg of testosterone |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
013 1件: 13 💬 |
180 |
Andrographolides |
- |
- |
- |
- |
013 1件: 13 💬 |
181 |
Anesthetic topical adhesive synera |
- |
- |
- |
- |
013 1件: 13 💬 |
182 |
Ank-700 |
- |
- |
- |
- |
013 1件: 13 💬 |
183 |
Anti lp40 antibody, subclass igg4 la294 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
184 |
Anti-cd25 humanized monoclonal antibody |
- |
- |
- |
- |
013 1件: 13 💬 |
185 |
Anti-cd52 monoclonal antibody |
- |
- |
- |
- |
013 1件: 13 💬 |
186 |
Anti-il-12 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
187 |
Anti-thymocyte globulin |
- |
- |
- |
- |
011 18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬 |
188 |
Anticholinergic medication |
- |
- |
- |
- |
013 1件: 13 💬 |
189 |
Anticuerpo monoclonal anti-lingo-1 humano |
- |
- |
- |
- |
013 1件: 13 💬 |
190 |
Antihistamine |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
191 |
Antimycotic |
- |
- |
- |
- |
013 1件: 13 💬 |
192 |
Antithymocyte |
- |
- |
- |
- |
013 1件: 13 💬 |
193 |
Antithymocyte gamma immunoglobulin |
- |
- |
- |
- |
013 1件: 13 💬 |
194 |
Antithymocyte immunoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 2件: 13, 96 💬 |
195 |
Antithymocyte immunoglobulin (rabbit) |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 2件: 13, 96 💬 |
196 |
Anxiety/depression and work and activities |
- |
- |
- |
- |
013 1件: 13 💬 |
197 |
Ap |
- |
- |
- |
- |
002 4件: 2 , 6 , 13, 299 💬 |
198 |
Apitox - pure honeybee toxin |
- |
- |
- |
- |
013 1件: 13 💬 |
199 |
Arbaclofen |
Arbaclofen |
1件: D09791 D09791 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 2件: 13, 206 💬 |
200 |
Arbaclofen er tablets |
Arbaclofen |
1件: D09791 D09791 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
201 |
Arbaclofen extended release tablets |
Arbaclofen |
1件: D09791 D09791 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
202 |
Arbaclofen placarbil |
Arbaclofen |
2件: D08861 D08861, D09791 D09791 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
203 |
Arbaclofen placarbil 15 mg bid |
Arbaclofen |
2件: D08861 D08861, D09791 D09791 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
204 |
Arbaclofen placarbil 30 mg bid |
Arbaclofen |
2件: D08861 D08861, D09791 D09791 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
205 |
Arbaclofen placarbil 45 mg bid |
Arbaclofen |
2件: D08861 D08861, D09791 D09791 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
206 |
Aricept |
- |
- |
- |
- |
006 4件: 6 , 13, 78, 124 💬 |
207 |
Aricept 10 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
208 |
Aricept 10 mg filmdragerade tabletter |
- |
- |
- |
- |
013 1件: 13 💬 |
209 |
Aricept 5 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
210 |
Aricept 5 mg filmdragerade tabletter |
- |
- |
- |
- |
013 1件: 13 💬 |
211 |
Arm 1 - geh120714 (18f) injection |
- |
- |
- |
- |
013 1件: 13 💬 |
212 |
Armodafinil |
Armodafinil |
1件: D03215 D03215 💬 |
SLC6A3 1件: SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 3件: 6 , 13, 84 💬 |
213 |
Arn-6039 |
- |
- |
- |
- |
013 1件: 13 💬 |
214 |
Arzerra |
- |
- |
- |
- |
013 1件: 13 💬 |
215 |
Arzerra® |
- |
- |
- |
- |
013 1件: 13 💬 |
216 |
Asa |
- |
- |
- |
- |
013 4件: 13, 96, 97, 251 💬 |
217 |
Asb-683699 |
- |
- |
- |
- |
013 1件: 13 💬 |
218 |
Aspirin |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 11件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231 💬 |
219 |
Aspirin 650mg oral capsule |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
220 |
Ata188 |
- |
- |
- |
- |
013 1件: 13 💬 |
221 |
Atacicept |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 4件: 13, 46, 49, 66 💬 |
222 |
Atacicept 150 mg |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 2件: 13, 49 💬 |
223 |
Atacicept 25 mg |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 2件: 13, 66 💬 |
224 |
Atacicept 75 mg |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 3件: 13, 49, 66 💬 |
225 |
Atg |
- |
- |
- |
- |
013 4件: 13, 60, 96, 285 💬 |
226 |
Atl1102 |
ATL1102 |
- |
- |
- |
013 1件: 13 💬 |
227 |
Atomoxetine |
Atomoxetine |
2件: D02574 D02574, D07473 D07473 💬 |
SLC6A2 1件: SLC6A2 💬 |
Synaptic vesicle cycle 1件: Synaptic vesicle cycle |
006 3件: 6 , 8 , 13 💬 |
228 |
Atorvastatin |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
229 |
Atx-ms-1467 |
- |
- |
- |
- |
013 1件: 13 💬 |
230 |
Aubagio |
- |
- |
- |
- |
013 1件: 13 💬 |
231 |
Aubagio - 14 mg - compressa rivestita con film - uso orale - blister (alu/alu) - 28 compresse |
- |
- |
- |
- |
013 1件: 13 💬 |
232 |
Aubagio® |
- |
- |
- |
- |
013 1件: 13 💬 |
233 |
Autologous adipose derived mesenchymal cells |
- |
- |
- |
- |
013 1件: 13 💬 |
234 |
Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved |
- |
- |
- |
- |
013 1件: 13 💬 |
235 |
Autologous bone marrow-derived mononuclear stem cells |
- |
- |
- |
- |
013 1件: 13 💬 |
236 |
Autologous cd4+t cells stimulated and expanded ex vivo by a mog peptide modified by the introduction of a thioreductase motif into the flanking residues of the t cell epitope |
- |
- |
- |
- |
013 1件: 13 💬 |
237 |
Autologous hematopoietic stem cell |
- |
- |
- |
- |
013 1件: 13 💬 |
238 |
Autologous hematopoietic stem cells |
- |
- |
- |
- |
013 1件: 13 💬 |
239 |
Autologous mesenchymal cell product |
- |
- |
- |
- |
013 1件: 13 💬 |
240 |
Autologous mesenchymal stem cell transplantation |
- |
- |
- |
- |
013 1件: 13 💬 |
241 |
Autologous mesenchymal stem cells |
- |
- |
- |
- |
002 5件: 2 , 6 , 13, 17, 46 💬 |
242 |
Autologous stem cells |
- |
- |
- |
- |
013 2件: 13, 51 💬 |
243 |
Autologous t-lymphocytes |
- |
- |
- |
- |
013 1件: 13 💬 |
244 |
Autologous vitd3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (toldc-vitd3) |
- |
- |
- |
- |
013 1件: 13 💬 |
245 |
Av605 |
- |
- |
- |
- |
013 1件: 13 💬 |
246 |
Avonex |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
247 |
Avonex (interferon beta 1a) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
248 |
Avonex (interferon beta-1a), biogen idec ltd |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
249 |
Avonex 30 microgram/0.5 ml solution for injection |
- |
- |
- |
- |
013 1件: 13 💬 |
250 |
Avonex 30 microgramos/0,5 ml (interferón beta - 1a) solución inyectable |
- |
- |
- |
- |
013 1件: 13 💬 |
251 |
Avonex 30 microgramos/0.5 ml solución para inyección |
- |
- |
- |
- |
013 1件: 13 💬 |
252 |
Avonex 30 µg/0,5 ml solution for injection |
- |
- |
- |
- |
013 1件: 13 💬 |
253 |
Avonex and topamax |
- |
- |
- |
- |
013 1件: 13 💬 |
254 |
Avonex im 4sir 30mcg/0,5ml 4ag |
- |
- |
- |
- |
013 1件: 13 💬 |
255 |
Avonex*im 4sir 30mcg/0,5ml+4ag |
- |
- |
- |
- |
013 1件: 13 💬 |
256 |
Avonex/betaseron/copaxone/rebif |
- |
- |
- |
- |
013 1件: 13 💬 |
257 |
Avonex/zocor |
- |
- |
- |
- |
013 1件: 13 💬 |
258 |
Avonex® |
- |
- |
- |
- |
013 1件: 13 💬 |
259 |
Avonex® monotherapy (6.0 miu administered i.m. each week) |
- |
- |
- |
- |
013 1件: 13 💬 |
260 |
Avp-923 |
- |
- |
- |
- |
002 3件: 2 , 6 , 13 💬 |
261 |
Azathioprine |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
006 20件: 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
262 |
Azathioprine (aza) |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
013 3件: 13, 19, 97 💬 |
263 |
Azatioprina |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
013 3件: 13, 96, 97 💬 |
264 |
Azatioprina hex. 50cpr 50mg bl |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
013 1件: 13 💬 |
265 |
Azithromycin |
Azithromycin |
3件: D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
013 6件: 13, 84, 85, 96, 228, 299 💬 |
266 |
Bacille calmette-guerin vaccine |
- |
- |
- |
- |
013 1件: 13 💬 |
267 |
Bacille of calmette-guerin |
- |
- |
- |
- |
013 1件: 13 💬 |
268 |
Baclofen |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
002 5件: 2 , 10, 13, 18, 149 💬 |
269 |
Baclofen 20 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
270 |
Baclofen er capsules (grs) 10 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
271 |
Baclofen er capsules (grs) 20 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
272 |
Baclofen er capsules (grs) 30mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
273 |
Baclofen er capsules (grs) 40mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
274 |
Baclofen er capsules (grs) 50 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
275 |
Baclofen ir |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
276 |
Baclofen tablets usp |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
277 |
Baclofen tablets usp 10 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
278 |
Baf312 |
- |
- |
- |
- |
013 2件: 13, 50 💬 |
279 |
Baf312 0,25 mg tablet |
- |
- |
- |
- |
013 1件: 13 💬 |
280 |
Baf312 1 mg tablet |
- |
- |
- |
- |
013 2件: 13, 50 💬 |
281 |
Baf312 4 mg tablet |
- |
- |
- |
- |
013 1件: 13 💬 |
282 |
Baf312 hemifumarate |
- |
- |
- |
- |
013 2件: 13, 50 💬 |
283 |
Baf312a |
- |
- |
- |
- |
013 1件: 13 💬 |
284 |
Bafiertam |
- |
- |
- |
- |
013 1件: 13 💬 |
285 |
Balance |
Isoxaflutole |
- |
- |
- |
005 9件: 5 , 6 , 13, 46, 81, 113, 122, 149, 299 💬 |
286 |
Baminercept |
Baminercept |
1件: D08866 D08866 💬 |
LTB 1件: LTB 💬 |
Cytokine-cytokine receptor interaction 3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 4件: 13, 46, 53, 97 💬 |
287 |
Baseline treatment |
- |
- |
- |
- |
013 1件: 13 💬 |
288 |
Bat4406f |
- |
- |
- |
- |
013 1件: 13 💬 |
289 |
Bay 79-4998 |
- |
- |
- |
- |
013 1件: 13 💬 |
290 |
Bay86-5046 |
- |
- |
- |
- |
013 1件: 13 💬 |
291 |
Bay86-5046_interferon-beta-1b |
- |
- |
- |
- |
013 1件: 13 💬 |
292 |
Bazedoxifene |
Bazedoxifene |
1件: D03062 D03062 💬 |
- |
- |
013 1件: 13 💬 |
293 |
Bazedoxifene acetate |
Acetate |
1件: D03062 D03062 💬 |
- |
- |
013 1件: 13 💬 |
294 |
Bbr 2778 |
- |
- |
- |
- |
011 2件: 11, 13 💬 |
295 |
Bcd-033 (interferon beta 1a) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
296 |
Bcd-054 180 mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
297 |
Bcd-054 240 mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
298 |
Bcd-063 |
- |
- |
- |
- |
013 1件: 13 💬 |
299 |
Bcd-132 |
- |
- |
- |
- |
013 1件: 13 💬 |
300 |
Bcd-132, 125 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
301 |
Bcd-132, 500 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
302 |
Bcg20-0134 |
- |
- |
- |
- |
013 1件: 13 💬 |
303 |
Beam regimen |
- |
- |
- |
- |
013 1件: 13 💬 |
304 |
Beetainterferoni -1a |
- |
- |
- |
- |
013 1件: 13 💬 |
305 |
Behavioral: 6 months weight resistance and balance program |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
306 |
Behavioral: adherence counseling |
- |
- |
- |
- |
013 1件: 13 💬 |
307 |
Behavioral: assessment of disability |
- |
- |
- |
- |
013 1件: 13 💬 |
308 |
Behavioral: assessment of impact of ms on cognition |
- |
- |
- |
- |
013 1件: 13 💬 |
309 |
Behavioral: balance training |
Isoxaflutole |
- |
- |
- |
006 2件: 6 , 13 💬 |
310 |
Behavioral: collaborative care (cc) |
- |
- |
- |
- |
013 1件: 13 💬 |
311 |
Behavioral: learning |
- |
- |
- |
- |
013 1件: 13 💬 |
312 |
Behavioral: medical marijuana |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
313 |
Behavioral: meditation |
- |
- |
- |
- |
013 1件: 13 💬 |
314 |
Behavioral: motivational interviewing |
- |
- |
- |
- |
013 1件: 13 💬 |
315 |
Behavioral: physical activity together for pwms and their cgs (pat-ms) |
- |
- |
- |
- |
013 1件: 13 💬 |
316 |
Behavioral: self massage |
- |
- |
- |
- |
013 1件: 13 💬 |
317 |
Behavioral: step tracking |
- |
- |
- |
- |
013 1件: 13 💬 |
318 |
Behavioral: telephone-based cognitive behavioral therapy |
- |
- |
- |
- |
013 1件: 13 💬 |
319 |
Behavioral: water tracking |
Water |
1件: D00001 D00001 💬 |
- |
- |
013 1件: 13 💬 |
320 |
Best available therapy (bat) |
- |
- |
- |
- |
013 1件: 13 💬 |
321 |
Beta-1b interferoni |
- |
- |
- |
- |
013 1件: 13 💬 |
322 |
Beta-alanine |
Alanine |
2件: D00012 D00012, D07561 D07561 💬 |
- |
- |
013 1件: 13 💬 |
323 |
Beta-alanine supplementation |
Alanine |
2件: D00012 D00012, D07561 D07561 💬 |
- |
- |
013 1件: 13 💬 |
324 |
Beta-carotene |
Beta carotene |
1件: D03101 D03101 💬 |
- |
- |
013 1件: 13 💬 |
325 |
Beta-interferon |
- |
- |
- |
- |
013 1件: 13 💬 |
326 |
Betacarotene |
Beta carotene |
1件: D03101 D03101 💬 |
- |
- |
013 1件: 13 💬 |
327 |
Betaferon |
- |
- |
- |
- |
013 1件: 13 💬 |
328 |
Betaferon 250 mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
329 |
Betaferon 250 microgram/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
330 |
Betaferon 250 microgram/ml, powder and solvent for solution for injection |
- |
- |
- |
- |
013 1件: 13 💬 |
331 |
Betaferon 250 microgram/ml, powder and solvent for solution for injection. |
- |
- |
- |
- |
013 1件: 13 💬 |
332 |
Betaferon 250 microgramos |
- |
- |
- |
- |
013 1件: 13 💬 |
333 |
Betaferon 250mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
334 |
Betaferon 250µg |
- |
- |
- |
- |
013 1件: 13 💬 |
335 |
Betaferon 500 mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
336 |
Betaferon 500 µg |
- |
- |
- |
- |
013 1件: 13 💬 |
337 |
Betaferon 500mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
338 |
Betaferon 500µg |
- |
- |
- |
- |
013 1件: 13 💬 |
339 |
Betaferon sc 15f 0,25mg 15sir |
- |
- |
- |
- |
013 1件: 13 💬 |
340 |
Betaferon*15confez 0,25mg/ml+ |
- |
- |
- |
- |
013 1件: 13 💬 |
341 |
Betaferon, bay 86-5046 |
- |
- |
- |
- |
013 1件: 13 💬 |
342 |
Betaferon/betaseron |
- |
- |
- |
- |
013 1件: 13 💬 |
343 |
Betaferon® |
- |
- |
- |
- |
013 1件: 13 💬 |
344 |
Betaferon® (interferon beta-1b) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
345 |
Betaseron |
- |
- |
- |
- |
013 1件: 13 💬 |
346 |
Betaseron (interferon beta-1b, bay86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
347 |
Betaseron (interferon beta-1b, bay86-5046), bayer healthcare ag |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
348 |
Bevacizumab |
Bevacizumab |
1件: D06409 D06409 💬 |
VEGFA 1件: VEGFA 💬 |
AGE-RAGE signaling pathway in diabetic complications 22件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway |
013 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬 |
349 |
Bexarotene |
Bexarotene |
1件: D03106 D03106 💬 |
RXRA 3件: RXRA, RXRB, RXRG 💬 |
Adipocytokine signaling pathway 15件: Adipocytokine signaling pathway, Bile secretion, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer |
013 2件: 13, 75 💬 |
350 |
Bg-12 120 |
- |
- |
- |
- |
013 1件: 13 💬 |
351 |
Bg00002 |
- |
- |
- |
- |
013 1件: 13 💬 |
352 |
Bg00002 (natalizumab) |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
353 |
Bg00002-e (natalizumab high titer) |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
354 |
Bg00012 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
355 |
Bg00012 (dmf) |
- |
- |
- |
- |
013 1件: 13 💬 |
356 |
Bg00012 (dmf) (tecfidera®.) |
- |
- |
- |
- |
013 1件: 13 💬 |
357 |
Bg0002 (natalizumab) |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
358 |
Bg9418 (interferon beta 1-a) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
359 |
Bg9418 (interferon beta-1a) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 2件: 13, 97 💬 |
360 |
Bgc20-0134 |
- |
- |
- |
- |
013 1件: 13 💬 |
361 |
Bgg492 |
- |
- |
- |
- |
013 1件: 13 💬 |
362 |
Bht-3009 |
- |
- |
- |
- |
013 1件: 13 💬 |
363 |
Bht-3009 0.5 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
364 |
Bht-3009 1.5 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
365 |
Bht-3009-01 |
- |
- |
- |
- |
013 1件: 13 💬 |
366 |
Biib017 |
- |
- |
- |
- |
013 1件: 13 💬 |
367 |
Biib017 (peginterferon beta-1a) |
Peginterferon beta-1a |
1件: D10483 D10483 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
368 |
Biib019 |
- |
- |
- |
- |
013 1件: 13 💬 |
369 |
Biib019 (daclizumab high yield process) |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
370 |
Biib019 (daclizumab) |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
371 |
Biib033 |
- |
- |
- |
- |
013 1件: 13 💬 |
372 |
Biib033 (anti-lingo) |
- |
- |
- |
- |
013 1件: 13 💬 |
373 |
Biib033 (anti-lingo) - ev substance code sub118957 |
- |
- |
- |
- |
013 1件: 13 💬 |
374 |
Biib033 (opicinumab) |
Opicinumab |
1件: D11767 D11767 💬 |
- |
- |
013 1件: 13 💬 |
375 |
Biib041 |
- |
- |
- |
- |
013 1件: 13 💬 |
376 |
Biib041 (fampridine) |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
377 |
Biib041 (fampridine-sr) |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
378 |
Biib041 (pr fampridine) |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
379 |
Biib061 |
- |
- |
- |
- |
013 1件: 13 💬 |
380 |
Biib133 |
- |
- |
- |
- |
013 1件: 13 💬 |
381 |
Biotin |
Biotin |
1件: D00029 D00029 💬 |
- |
- |
002 5件: 2 , 8 , 10, 13, 20 💬 |
382 |
Biotina |
Biotin |
1件: D00029 D00029 💬 |
- |
- |
013 1件: 13 💬 |
383 |
Birt 2584 xx |
- |
- |
- |
- |
013 1件: 13 💬 |
384 |
Birt 2584xx |
- |
- |
- |
- |
013 1件: 13 💬 |
385 |
Bisacodyl |
Bisacodyl |
1件: D00245 D00245 💬 |
- |
- |
013 1件: 13 💬 |
386 |
Blood sample |
- |
- |
- |
- |
008 13件: 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
387 |
Blood samples |
- |
- |
- |
- |
013 8件: 13, 41, 46, 51, 61, 97, 227, 271 💬 |
388 |
Blood sampling |
- |
- |
- |
- |
013 5件: 13, 17, 19, 51, 96 💬 |
389 |
Bmmnc |
- |
- |
- |
- |
013 1件: 13 💬 |
390 |
Bms 188667 (abatacept) |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
013 1件: 13 💬 |
391 |
Bone marrow autologous mesenchymal stem cells transplantation |
- |
- |
- |
- |
013 1件: 13 💬 |
392 |
Borage oil |
Borage oil |
- |
- |
- |
013 1件: 13 💬 |
393 |
Borage oil 20% gla |
Borage oil |
- |
- |
- |
013 1件: 13 💬 |
394 |
Bortezomib |
Bortezomib |
1件: D03150 D03150 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
395 |
Bosentan |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
396 |
Boswelan |
- |
- |
- |
- |
013 1件: 13 💬 |
397 |
Boswellia serrata |
Indian frankincense |
- |
- |
- |
013 1件: 13 💬 |
398 |
Boswellia serrata extract |
Indian frankincense |
- |
- |
- |
013 1件: 13 💬 |
399 |
Boswellia serrata extract ps0201bo capsules |
Indian frankincense |
- |
- |
- |
013 1件: 13 💬 |
400 |
Boswellic acids (boswelan) |
- |
- |
- |
- |
013 1件: 13 💬 |
401 |
Botox |
- |
- |
- |
- |
002 6件: 2 , 6 , 13, 51, 149, 226 💬 |
402 |
Botox® |
- |
- |
- |
- |
013 1件: 13 💬 |
403 |
Botulinum toxin |
- |
- |
- |
- |
006 3件: 6 , 13, 149 💬 |
404 |
Botulinum toxin a |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
013 4件: 13, 51, 149, 226 💬 |
405 |
Botulinum toxin a - haemagglutinin complex |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
013 1件: 13 💬 |
406 |
Botulinum toxin type a |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
002 10件: 2 , 5 , 6 , 7 , 13, 15, 17, 70, 113, 149 💬 |
407 |
Botulinum toxin type a 200u |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
013 1件: 13 💬 |
408 |
Botulinum toxin type a 300u |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
013 1件: 13 💬 |
409 |
Botulinum toxin type a infiltrations |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
013 1件: 13 💬 |
410 |
Brimonidine |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 2件: 13, 90 💬 |
411 |
Brimonidine tartrate |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 2件: 13, 90 💬 |
412 |
Bx-1 |
- |
- |
- |
- |
013 1件: 13 💬 |
413 |
C1-esterase inhibitor (cinryze) |
- |
- |
- |
- |
013 1件: 13 💬 |
414 |
C105 |
- |
- |
- |
- |
013 1件: 13 💬 |
415 |
Caffeine |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 9件: 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
416 |
Calcio |
Calcium |
- |
- |
- |
013 1件: 13 💬 |
417 |
Calcio folinato dc.it |
Calcium |
- |
- |
- |
013 1件: 13 💬 |
418 |
Calcium |
Calcium |
- |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
419 |
Calcium and vitamin d combination |
Calcium |
- |
- |
- |
013 1件: 13 💬 |
420 |
Calcium carbonate |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
013 8件: 13, 19, 46, 53, 75, 96, 235, 299 💬 |
421 |
Calcium levofolinate |
Calcium |
- |
- |
- |
013 1件: 13 💬 |
422 |
Cannabidiol |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 17件: 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
423 |
Cannabidiol / dronabinol capsule 5 mg+2,5 mg |
Cannabidiol |
2件: D00306 D00306, D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
424 |
Cannabidiol botanical drug substance (cbd bds) |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
425 |
Cannabidiol capsule 5 mg |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
426 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 8件: 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
427 |
Cannabis based medicine extract (sativex) |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
428 |
Cannabis, medical |
Medical Cannabis |
- |
- |
- |
002 5件: 2 , 6 , 13, 96, 97 💬 |
429 |
Cannador |
- |
- |
- |
- |
013 1件: 13 💬 |
430 |
Caprylic triglyceride |
Tricaprylin |
- |
- |
- |
013 1件: 13 💬 |
431 |
Capsules with 160 mg teavigo (at least 94% egcg) |
Epigallocatechin gallate |
- |
- |
- |
013 1件: 13 💬 |
432 |
Carbamazepine |
Carbamazepine |
1件: D00252 D00252 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 2件: 13, 231 💬 |
433 |
Carbidopa |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
434 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 12件: 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
435 |
Carmustine |
Carmustine |
1件: D00254 D00254 💬 |
- |
- |
011 5件: 11, 13, 14, 28, 60 💬 |
436 |
Carmustine, etoposide, cytarabine, and melphalan (beam) |
Carmustine |
7件: D00125 D00125, D00168 D00168, D00254 D00254, D00369 D00369, D03046 D03046, D03637 D03637, D04107 D04107 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
013 1件: 13 💬 |
437 |
Carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 8件: 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
438 |
Carnosine |
Carnosine |
- |
- |
- |
006 2件: 6 , 13 💬 |
439 |
Carnosine, capsulle, 2 g/day, 8 weeks |
Carnosine |
- |
- |
- |
013 1件: 13 💬 |
440 |
Cbd |
- |
- |
- |
- |
002 11件: 2 , 6 , 8 , 13, 46, 140, 144, 145, 156, 158, 206 💬 |
441 |
Cc |
- |
- |
- |
- |
013 13件: 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
442 |
Cci-779 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
443 |
Cdp323 |
CDP323 |
- |
- |
- |
013 1件: 13 💬 |
444 |
Cellcept |
- |
- |
- |
- |
011 5件: 11, 13, 42, 43, 49 💬 |
445 |
Cellular therapy with ebv specific autologous ctl infusion |
- |
- |
- |
- |
013 1件: 13 💬 |
446 |
Ceralifimod |
Ceralifimod |
- |
- |
- |
013 1件: 13 💬 |
447 |
Ceralifmod |
- |
- |
- |
- |
013 1件: 13 💬 |
448 |
Cesamet™ (nabilone) |
Nabilone |
1件: D05099 D05099 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
449 |
Ceterizine |
- |
- |
- |
- |
013 1件: 13 💬 |
450 |
Cetirizina |
Cetirizine |
2件: D00664 D00664, D07662 D07662 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
451 |
Cetirizina mylan generics |
Cetirizine |
2件: D00664 D00664, D07662 D07662 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
452 |
Cetirizine |
Cetirizine |
2件: D00664 D00664, D07662 D07662 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 2件: 13, 35 💬 |
453 |
Cetirizine hydrochloride |
Cetirizine |
2件: D00664 D00664, D07662 D07662 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
454 |
Cgp 77116 |
- |
- |
- |
- |
013 1件: 13 💬 |
455 |
Charcoal |
- |
- |
- |
- |
013 1件: 13 💬 |
456 |
Chloride |
Chloride ion |
- |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
457 |
Cholecalciferol |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 9件: 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
458 |
Cholecalciferol (vitamin d3) |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 2件: 13, 299 💬 |
459 |
Cholecalciferol, vitamin d3 |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 1件: 13 💬 |
460 |
Cholestyramine |
Cholestyramine |
- |
- |
- |
013 2件: 13, 79 💬 |
461 |
Chr-1103 / gbr500 |
- |
- |
- |
- |
013 1件: 13 💬 |
462 |
Cianocobalamina |
Cyanocobalamin |
4件: D00166 D00166, D03615 D03615, D03616 D03616, D03617 D03617 💬 |
- |
- |
013 1件: 13 💬 |
463 |
Cianocobalamina fu dc.it |
Cyanocobalamin |
4件: D00166 D00166, D03615 D03615, D03616 D03616, D03617 D03617 💬 |
- |
- |
013 1件: 13 💬 |
464 |
Ciclofosfamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 1件: 13 💬 |
465 |
Cinryze |
- |
- |
- |
- |
013 2件: 13, 61 💬 |
466 |
Circadin |
- |
- |
- |
- |
006 3件: 6 , 13, 90 💬 |
467 |
Circadin ( inn= melatonin) |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
468 |
Cisapride |
Cisapride |
2件: D00274 D00274, D02092 D02092 💬 |
HTR2A 3件: HTR2A, HTR3A, HTR4 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
469 |
Citalopram |
Citalopram |
2件: D00822 D00822, D07704 D07704 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 6件: 6 , 8 , 13, 18, 46, 127 💬 |
470 |
Citochine ed immunomodulatori |
- |
- |
- |
- |
013 1件: 13 💬 |
471 |
Cladribina |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
472 |
Cladribina oral |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
473 |
Cladribine |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 2件: 13, 94 💬 |
474 |
Cladribine 3.5 mg/kg |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
475 |
Cladribine 5.25 mg/kg |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
476 |
Cladribine oral tablet |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
477 |
Cladribine tablet |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
478 |
Cladribine tablets |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
479 |
Clemastine |
Clemastine |
2件: D00666 D00666, D03535 D03535 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
480 |
Clemastine fumarate |
Clemastine |
2件: D00666 D00666, D03535 D03535 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
481 |
Clostridium botulinum |
Clostridium botulinum |
- |
- |
- |
013 1件: 13 💬 |
482 |
Clostridium botulinum toxin type a |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
013 1件: 13 💬 |
483 |
Cnm-au8 |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
484 |
Cnp-ms-0601 |
- |
- |
- |
- |
013 1件: 13 💬 |
485 |
Cnto 1275 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
486 |
Co |
- |
- |
- |
- |
006 5件: 6 , 13, 53, 70, 85 💬 |
487 |
Co-14 |
- |
- |
- |
- |
013 1件: 13 💬 |
488 |
Coconut |
Coconut |
- |
- |
- |
013 2件: 13, 53 💬 |
489 |
Coconut oil |
Coconut |
1件: D05326 D05326 💬 |
- |
- |
013 1件: 13 💬 |
490 |
Coconut oil and epigallocatechin gallate |
Coconut |
1件: D05326 D05326 💬 |
- |
- |
013 1件: 13 💬 |
491 |
Coenzyme q |
- |
- |
- |
- |
013 1件: 13 💬 |
492 |
Colecalciferol |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 4件: 13, 46, 96, 228 💬 |
493 |
Colecalciferol concentrate (oily form) |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 1件: 13 💬 |
494 |
Combination product: ofatumumab with ai |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
495 |
Combination product: ofatumumab with prf |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
496 |
Cop |
- |
- |
- |
- |
013 1件: 13 💬 |
497 |
Cop-1 |
Glatiramer |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
498 |
Cop-1/copolymer-1 |
Glatiramer |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
499 |
Copaxone |
- |
- |
- |
- |
013 1件: 13 💬 |
500 |
Copaxone - 20 mg/ml soluzione iniettabile in siringhe preriempite 30 siringhe |
- |
- |
- |
- |
013 1件: 13 💬 |
501 |
Copaxone - 40 mg/ml soluzione iniettabile in siringa preriempita 12 siringhe preriempite da 1 ml con ago |
- |
- |
- |
- |
013 1件: 13 💬 |
502 |
Copaxone 20 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
503 |
Copaxone 20 mg/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
504 |
Copaxone 20 mg/ml solución inyectable en jeringa precargada |
- |
- |
- |
- |
013 1件: 13 💬 |
505 |
Copaxone 20 mg/ml solución para inyección en jeringa precargada |
- |
- |
- |
- |
013 1件: 13 💬 |
506 |
Copaxone 20 mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 1件: 13 💬 |
507 |
Copaxone 20 mg/ml, solution for injection, pre-filled syringes |
- |
- |
- |
- |
013 1件: 13 💬 |
508 |
Copaxone 20mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 1件: 13 💬 |
509 |
Copaxone 40 mg/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
510 |
Copaxone 40 mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 1件: 13 💬 |
511 |
Copaxone subcutaneous injection syringe |
- |
- |
- |
- |
013 1件: 13 💬 |
512 |
Copaxone*sc 28sir 20mg/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
513 |
Copaxone-teva |
- |
- |
- |
- |
013 1件: 13 💬 |
514 |
Copaxone® |
- |
- |
- |
- |
013 1件: 13 💬 |
515 |
Copolymer 1 |
- |
- |
- |
- |
013 1件: 13 💬 |
516 |
Copolymer-1 |
Glatiramer |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
517 |
Corticosteroid |
- |
- |
- |
- |
013 10件: 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 💬 |
518 |
Corticosteroids & tancart19/20 |
- |
- |
- |
- |
013 1件: 13 💬 |
519 |
Corticotropin |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 7件: 2 , 13, 46, 75, 78, 84, 222 💬 |
520 |
Cranberry |
Cranberry |
- |
- |
- |
013 1件: 13 💬 |
521 |
Creatine |
Creatine |
- |
- |
- |
001 12件: 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
522 |
Cs-0777 tablets |
- |
- |
- |
- |
013 1件: 13 💬 |
523 |
Ct103a cells |
- |
- |
- |
- |
013 1件: 13 💬 |
524 |
Curcumin |
Curcumin |
- |
- |
- |
002 11件: 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
525 |
Cyclophosfamide |
- |
- |
- |
- |
013 1件: 13 💬 |
526 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
527 |
Cyclophosphamide (drug) |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 1件: 13 💬 |
528 |
Cyclophosphamide and atg |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 1件: 13 💬 |
529 |
Cyclophosphamide and fludarabine |
Cyclophosphamide |
4件: D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
530 |
Cyclophosphamide monohydrate |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 4件: 13, 60, 96, 256 💬 |
531 |
Cyclophosphamide/glatiramer acetate |
Acetate |
3件: D00287 D00287, D04318 D04318, D07760 D07760 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
532 |
Cymbalta |
- |
- |
- |
- |
006 3件: 6 , 13, 49 💬 |
533 |
Cysteine |
Cysteine |
2件: D00026 D00026, D02326 D02326 💬 |
- |
- |
006 11件: 6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
534 |
Cytarabine |
Cytarabine |
3件: D00168 D00168, D03046 D03046, D03637 D03637 💬 |
- |
- |
011 6件: 11, 13, 14, 25, 49, 60 💬 |
535 |
Cytolytic cd4+ t cells |
- |
- |
- |
- |
013 1件: 13 💬 |
536 |
Cápsulas de laquinimod 0.6 mg |
Laquinimod |
- |
- |
- |
013 1件: 13 💬 |
537 |
Células madre mesenquimales |
- |
- |
- |
- |
013 1件: 13 💬 |
538 |
D mannose |
Mannose |
- |
- |
- |
013 1件: 13 💬 |
539 |
D-aspartate |
- |
- |
- |
- |
013 1件: 13 💬 |
540 |
D-biotin |
Biotin |
1件: D00029 D00029 💬 |
- |
- |
010 3件: 10, 13, 20 💬 |
541 |
D-biotina |
Biotin |
1件: D00029 D00029 💬 |
- |
- |
013 1件: 13 💬 |
542 |
Dac |
- |
- |
- |
- |
013 3件: 13, 90, 301 💬 |
543 |
Dac hyp |
- |
- |
- |
- |
013 1件: 13 💬 |
544 |
Dac-hyp |
- |
- |
- |
- |
013 1件: 13 💬 |
545 |
Daclizumab |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 7件: 13, 56, 60, 65, 97, 283, 284 💬 |
546 |
Daclizumab (anti-cd25 humanized monoclonal antibody) |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
547 |
Daclizumab high yield process |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
548 |
Daclizumab hyp |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
549 |
Daclizumab hyp (dac hyp |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
550 |
Daclizumab hyp (dac hyp) |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
551 |
Daclizumab wih greek suffix |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
552 |
Daclizumab with greek suufix |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
553 |
Dalfampridine |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
004 2件: 4 , 13 💬 |
554 |
Dalfampridine er |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
555 |
Dalfampridine-er 10mg |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
556 |
Dalfampridine-er 5mg |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
557 |
Dantrolene |
Dantrolene |
2件: D02274 D02274, D02347 D02347 💬 |
- |
- |
013 2件: 13, 233 💬 |
558 |
Dapirolizumab pegol |
Dapirolizumab pegol |
- |
- |
- |
013 2件: 13, 49 💬 |
559 |
Darifenacin |
Darifenacin |
2件: D01699 D01699, D03654 D03654 💬 |
CHRM3 1件: CHRM3 💬 |
Alzheimer disease 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
006 2件: 6 , 13 💬 |
560 |
Darifenacin (bay79-4998) |
Darifenacin |
2件: D01699 D01699, D03654 D03654 💬 |
CHRM3 1件: CHRM3 💬 |
Alzheimer disease 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
013 1件: 13 💬 |
561 |
Dc-tab |
- |
- |
- |
- |
013 1件: 13 💬 |
562 |
Dekristol |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
563 |
Dekristol 20000 ie |
- |
- |
- |
- |
013 1件: 13 💬 |
564 |
Dekristol® 400-tabletten |
- |
- |
- |
- |
013 1件: 13 💬 |
565 |
Dekristol®-tablette 1 (400 ie) |
- |
- |
- |
- |
013 1件: 13 💬 |
566 |
Delta-9-tetrahydrocannabinol |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 2件: 8 , 13 💬 |
567 |
Demestril septem |
- |
- |
- |
- |
013 1件: 13 💬 |
568 |
Device: 2 ma transcranial direct current stimulation |
- |
- |
- |
- |
013 1件: 13 💬 |
569 |
Device: 4 ma transcranial direct current stimulation |
- |
- |
- |
- |
013 1件: 13 💬 |
570 |
Device: avonex prefilled syringe via manual im injection |
- |
- |
- |
- |
013 1件: 13 💬 |
571 |
Device: balance platform therapy |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
572 |
Device: betaconnect |
- |
- |
- |
- |
013 1件: 13 💬 |
573 |
Device: betaconnect auto-injector |
- |
- |
- |
- |
013 1件: 13 💬 |
574 |
Device: betaconnect auto-injector. |
- |
- |
- |
- |
013 1件: 13 💬 |
575 |
Device: betaconnect autoinjector |
- |
- |
- |
- |
013 1件: 13 💬 |
576 |
Device: betaconnect device |
- |
- |
- |
- |
013 1件: 13 💬 |
577 |
Device: biib017 (peginterferon beta-1a) autoinjector |
Peginterferon beta-1a |
1件: D10483 D10483 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
578 |
Device: biib017 (peginterferon beta-1a) pre-filled syringe (pfs) |
Peginterferon beta-1a |
1件: D10483 D10483 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
579 |
Device: capacity of muscular oxygen extraction |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
013 1件: 13 💬 |
580 |
Device: cic using lofric primo |
- |
- |
- |
- |
013 1件: 13 💬 |
581 |
Device: dynamic vessel analyzer (dva) |
- |
- |
- |
- |
013 1件: 13 💬 |
582 |
Device: extracorporeal photopheresis |
- |
- |
- |
- |
013 1件: 13 💬 |
583 |
Device: four-point cane (fpc) |
- |
- |
- |
- |
013 1件: 13 💬 |
584 |
Device: fourier domain doppler optical coherence tomography (fdoct) |
- |
- |
- |
- |
013 1件: 13 💬 |
585 |
Device: interferon beta-1a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
586 |
Device: lokomat training |
- |
- |
- |
- |
013 1件: 13 💬 |
587 |
Device: magnetic resonance imaging |
- |
- |
- |
- |
006 5件: 6 , 13, 22, 34, 299 💬 |
588 |
Device: medication event monitoring system (mems) |
- |
- |
- |
- |
013 1件: 13 💬 |
589 |
Device: metabolic fatigue |
- |
- |
- |
- |
013 1件: 13 💬 |
590 |
Device: mybetaapp |
- |
- |
- |
- |
013 1件: 13 💬 |
591 |
Device: neuromuscular electrical stimulation delivered using the electrical therapy device empi 300 pv |
- |
- |
- |
- |
013 1件: 13 💬 |
592 |
Device: nintendo wii fit balance board |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
593 |
Device: nirs after bosentan administration |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
594 |
Device: nirs baseline |
- |
- |
- |
- |
013 1件: 13 💬 |
595 |
Device: optical coherence tomography (oct) |
- |
- |
- |
- |
013 1件: 13 💬 |
596 |
Device: optical coherence tomography angiography (octa) |
- |
- |
- |
- |
013 1件: 13 💬 |
597 |
Device: paired associative stimulation (pas) |
- |
- |
- |
- |
013 1件: 13 💬 |
598 |
Device: repetitive transcranial magnetic stimulation (rtms) |
- |
- |
- |
- |
013 1件: 13 💬 |
599 |
Device: sham transcranial direct current stimulation (tdcs) |
- |
- |
- |
- |
013 1件: 13 💬 |
600 |
Device: single-point cane (spc) |
- |
- |
- |
- |
013 1件: 13 💬 |
601 |
Device: single-pulse transcranial magnetic stimulation (sptms) |
- |
- |
- |
- |
013 1件: 13 💬 |
602 |
Device: single-use autoinjector |
- |
- |
- |
- |
013 1件: 13 💬 |
603 |
Device: single-use autoinjector with a prefilled liquid avonex syringe |
- |
- |
- |
- |
013 1件: 13 💬 |
604 |
Device: sleep assessment |
- |
- |
- |
- |
013 1件: 13 💬 |
605 |
Device: tcd after bosentan administration |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
606 |
Device: tcd baseline |
- |
- |
- |
- |
013 1件: 13 💬 |
607 |
Device: transcranial magnetic stimulation (tms) |
- |
- |
- |
- |
013 1件: 13 💬 |
608 |
Device: trekking pole (tp). |
- |
- |
- |
- |
013 1件: 13 💬 |
609 |
Device: video game therapy |
- |
- |
- |
- |
013 1件: 13 💬 |
610 |
Device: wristband physical activity monitor |
Methamidophos |
- |
- |
- |
013 1件: 13 💬 |
611 |
Dexamethason |
- |
- |
- |
- |
013 4件: 13, 28, 46, 331 💬 |
612 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
613 |
Dexamethasone soduim phosphate |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
614 |
Dexchlorpheniramine |
Dexchlorpheniramine |
1件: D07803 D07803 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
615 |
Dexrazoxane |
Dexrazoxane |
1件: D03730 D03730 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
013 1件: 13 💬 |
616 |
Dexrazoxane (drz) plus mitoxantrone (mx) |
Dexrazoxane |
3件: D02166 D02166, D03730 D03730, D08224 D08224 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
013 1件: 13 💬 |
617 |
Dextromethorphan |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 11件: 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
618 |
Dextromethorphan hydrobromide |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 2件: 13, 46 💬 |
619 |
Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 2件: 2 , 13 💬 |
620 |
Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 2件: 2 , 13 💬 |
621 |
Dextromethorphan/quinidine |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
622 |
Dextrometorfano |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 1件: 13 💬 |
623 |
Dextrometorfano hidrobromuro |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 1件: 13 💬 |
624 |
Dextrometorfano/quinidina |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
625 |
Diagnostic test: entire-body pet-ct scans |
- |
- |
- |
- |
013 1件: 13 💬 |
626 |
Diagnostic test: oral glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
013 3件: 13, 65, 299 💬 |
627 |
Diagnostic test: pet with [11c]flumazenil |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
013 1件: 13 💬 |
628 |
Diagnostic test: stroop test |
- |
- |
- |
- |
013 1件: 13 💬 |
629 |
Diagnostic test: testing of autonomous nervous system function |
- |
- |
- |
- |
013 1件: 13 💬 |
630 |
Diazoxide |
Diazoxide |
1件: D00294 D00294 💬 |
ABCC8 2件: ABCC8, KCNJ11 💬 |
ABC transporters 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
013 2件: 13, 193 💬 |
631 |
Dibase |
- |
- |
- |
- |
013 1件: 13 💬 |
632 |
Diclofenac |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 4件: 13, 34, 46, 271 💬 |
633 |
Diclofenac sodium topical gel |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
634 |
Dietary supplement: vitamin a |
Vitamin A |
2件: D00069 D00069, D06543 D06543 💬 |
RARA 2件: RARA, RARB 💬 |
Acute myeloid leukemia 8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer |
013 1件: 13 💬 |
635 |
Dimethyl fumarate |
Dimethyl fumarate |
1件: D03846 D03846 💬 |
KEAP1 1件: KEAP1 💬 |
Fluid shear stress and atherosclerosis 4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 4件: 13, 51, 86, 296 💬 |
636 |
Dimethyl fumarate (dmf) |
Dimethyl fumarate |
1件: D03846 D03846 💬 |
KEAP1 1件: KEAP1 💬 |
Fluid shear stress and atherosclerosis 4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 3件: 13, 51, 86 💬 |
637 |
Dimethyl fumarate 240 mg |
Dimethyl fumarate |
1件: D03846 D03846 💬 |
KEAP1 1件: KEAP1 💬 |
Fluid shear stress and atherosclerosis 4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 1件: 13 💬 |
638 |
Dimethyl fumarate [dmf] |
Dimethyl fumarate |
1件: D03846 D03846 💬 |
KEAP1 1件: KEAP1 💬 |
Fluid shear stress and atherosclerosis 4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 1件: 13 💬 |
639 |
Dimetilfumarato |
- |
- |
- |
- |
013 1件: 13 💬 |
640 |
Diphenydramine |
- |
- |
- |
- |
013 1件: 13 💬 |
641 |
Diphtheria toxoid |
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
013 2件: 13, 46 💬 |
642 |
Diroximel fumarate |
Diroximel fumarate |
1件: D11154 D11154 💬 |
- |
- |
013 1件: 13 💬 |
643 |
Diroximel fumarate (drf) |
Diroximel fumarate |
1件: D11154 D11154 💬 |
- |
- |
013 1件: 13 💬 |
644 |
Dirucotide |
Dirucotide |
1件: D09396 D09396 💬 |
- |
- |
013 1件: 13 💬 |
645 |
Dirucotide acetate |
Acetate |
1件: D09396 D09396 💬 |
- |
- |
013 1件: 13 💬 |
646 |
Discontinuation of disease modifying therapy |
- |
- |
- |
- |
013 1件: 13 💬 |
647 |
Disease modifying therapy |
- |
- |
- |
- |
013 1件: 13 💬 |
648 |
Dmt |
- |
- |
- |
- |
013 1件: 13 💬 |
649 |
Dmt continuation |
- |
- |
- |
- |
013 1件: 13 💬 |
650 |
Domperidone |
Domperidone |
2件: D01745 D01745, D07868 D07868 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 5件: 6 , 13, 17, 51, 230 💬 |
651 |
Donepezil |
Donepezil |
2件: D00670 D00670, D07869 D07869 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
005 9件: 5 , 6 , 13, 46, 78, 124, 127, 156, 206 💬 |
652 |
Donepezil hci (drug) |
Donepezil |
2件: D00670 D00670, D07869 D07869 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
013 1件: 13 💬 |
653 |
Dosing interruption of natalizumab |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
654 |
Dotarem |
- |
- |
- |
- |
013 1件: 13 💬 |
655 |
Dotarem 0,5mmol/ml, |
- |
- |
- |
- |
013 1件: 13 💬 |
656 |
Doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
013 15件: 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
657 |
Dpa |
- |
- |
- |
- |
002 4件: 2 , 6 , 13, 85 💬 |
658 |
Dpa-714 pet/mri |
- |
- |
- |
- |
013 1件: 13 💬 |
659 |
Dronabinol |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 5件: 2 , 13, 46, 271, 298 💬 |
660 |
Dronabinol 25 mg/ml, oral drops |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
661 |
Dronabinol capsule 2,5 mg |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
662 |
Duloxetine |
Duloxetine |
2件: D01179 D01179, D07880 D07880 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 2件: 6 , 13 💬 |
663 |
Duloxetine hydrochloride (hci) |
Duloxetine |
2件: D01179 D01179, D07880 D07880 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
013 1件: 13 💬 |
664 |
Dydrogesterone |
Dydrogesterone |
1件: D01217 D01217 💬 |
PGR 1件: PGR 💬 |
Breast cancer 4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 1件: 13 💬 |
665 |
Dysport |
- |
- |
- |
- |
013 2件: 13, 36 💬 |
666 |
Dysport*sc im 2fl 500u |
- |
- |
- |
- |
013 1件: 13 💬 |
667 |
Dysport® |
- |
- |
- |
- |
013 1件: 13 💬 |
668 |
Early highly effective therapies group |
- |
- |
- |
- |
013 1件: 13 💬 |
669 |
Ebixa |
- |
- |
- |
- |
002 3件: 2 , 6 , 13 💬 |
670 |
Ecp002a |
- |
- |
- |
- |
013 1件: 13 💬 |
671 |
Eculizumab |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
011 8件: 11, 13, 14, 61, 62, 109, 222, 223 💬 |
672 |
Efalizumab |
Efalizumab |
1件: D03959 D03959 💬 |
ITGAL 1件: ITGAL 💬 |
Cell adhesion molecules 12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis |
011 8件: 11, 13, 37, 46, 53, 61, 95, 96 💬 |
673 |
Egb 761® (tanakan®) |
Ginkgo biloba |
- |
- |
- |
013 1件: 13 💬 |
674 |
Egcg |
Epigallocatechin gallate |
- |
- |
- |
006 9件: 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
675 |
Ek-12 |
- |
- |
- |
- |
013 1件: 13 💬 |
676 |
Elezanumab |
Elezanumab |
1件: D11355 D11355 💬 |
RGMA 1件: RGMA 💬 |
Axon guidance 2件: Axon guidance, TGF-beta signaling pathway |
013 1件: 13 💬 |
677 |
Elnd002 |
- |
- |
- |
- |
013 1件: 13 💬 |
678 |
Emd 28162 |
- |
- |
- |
- |
013 1件: 13 💬 |
679 |
Emselex |
- |
- |
- |
- |
013 1件: 13 💬 |
680 |
Emselex 15 mg retardtabletten |
- |
- |
- |
- |
013 1件: 13 💬 |
681 |
Emselex 7,5 mg retardtabletten |
- |
- |
- |
- |
013 1件: 13 💬 |
682 |
Ena713 |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
683 |
Encapsulated baclofen 20 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
684 |
Encapsulated simvastatin tablets |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
685 |
Endoxan |
- |
- |
- |
- |
013 7件: 13, 28, 43, 44, 85, 96, 222 💬 |
686 |
Endoxan - ciclofosfamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 1件: 13 💬 |
687 |
Endoxan baxter |
- |
- |
- |
- |
013 3件: 13, 43, 96 💬 |
688 |
Enriched hematopoetic stem cell infusion |
- |
- |
- |
- |
013 3件: 13, 19, 284 💬 |
689 |
Enspryng |
- |
- |
- |
- |
013 1件: 13 💬 |
690 |
Eparmefolin 30 cpr 0,1/0,5mg |
- |
- |
- |
- |
013 1件: 13 💬 |
691 |
Epigallocatechin |
Epigallocatechin |
- |
- |
- |
008 5件: 8 , 13, 28, 85, 113 💬 |
692 |
Epigallocatechin gallate |
Epigallocatechin |
- |
- |
- |
013 1件: 13 💬 |
693 |
Epigallocatechin-gallate (sunphenon) |
Epigallocatechin |
- |
- |
- |
013 1件: 13 💬 |
694 |
Epo |
- |
- |
- |
- |
013 1件: 13 💬 |
695 |
Epoetin alfa |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
013 3件: 13, 18, 46 💬 |
696 |
Epoetin beta |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
013 1件: 13 💬 |
697 |
Equal |
- |
- |
- |
- |
006 5件: 6 , 13, 67, 86, 230 💬 |
698 |
Erypo/erypo fs |
- |
- |
- |
- |
013 1件: 13 💬 |
699 |
Erythropoietin |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 9件: 2 , 6 , 13, 18, 22, 47, 70, 95, 96 💬 |
700 |
Escalation therapies group |
- |
- |
- |
- |
013 1件: 13 💬 |
701 |
Escitalopram |
Escitalopram |
3件: D02567 D02567, D07704 D07704, D07913 D07913 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
002 3件: 2 , 6 , 13 💬 |
702 |
Escitalopram oxalate antidepressant |
Escitalopram |
3件: D02567 D02567, D07704 D07704, D07913 D07913 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
013 1件: 13 💬 |
703 |
Esomeprazole |
Esomeprazole |
4件: D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 6件: 13, 46, 86, 98, 298, 299 💬 |
704 |
Essential - hydroxytyrosol |
Hydroxytyrosol |
- |
- |
- |
013 1件: 13 💬 |
705 |
Essential fatty acids |
- |
- |
- |
- |
013 1件: 13 💬 |
706 |
Estradiol |
Estradiol |
8件: D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 5件: 13, 46, 49, 226, 299 💬 |
707 |
Estradiol hemihydrate |
Estradiol |
8件: D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 1件: 13 💬 |
708 |
Estriol |
Estriol |
2件: D00185 D00185, D01986 D01986 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 2件: 13, 227 💬 |
709 |
Estroprogestins |
- |
- |
- |
- |
013 1件: 13 💬 |
710 |
Eszopiclone |
Eszopiclone |
1件: D02624 D02624 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 3件: 6 , 13, 46 💬 |
711 |
Ethinylestradiol |
Ethinylestradiol |
1件: D00554 D00554 💬 |
ESR1 1件: ESR1 💬 |
Breast cancer 8件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 1件: 13 💬 |
712 |
Etifoxine |
Etifoxine |
1件: D07320 D07320 💬 |
- |
- |
013 1件: 13 💬 |
713 |
Etims |
- |
- |
- |
- |
013 1件: 13 💬 |
714 |
Etims (edc-fixed autologous pbmcs coupled with 7 immunodominant myelin peptides in ms patients) |
- |
- |
- |
- |
013 1件: 13 💬 |
715 |
Etoposide |
Etoposide |
2件: D00125 D00125, D04107 D04107 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
011 11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬 |
716 |
Eu/1/08/454/001-002, eu/1/08/454/005-007 |
- |
- |
- |
- |
013 1件: 13 💬 |
717 |
Eu/1/95/003/005-010 |
- |
- |
- |
- |
013 1件: 13 💬 |
718 |
Eu/1/97/033/002 |
- |
- |
- |
- |
013 1件: 13 💬 |
719 |
Eu/1/98/063/001-003 |
- |
- |
- |
- |
013 1件: 13 💬 |
720 |
Eu/1/98/063/004-006 |
- |
- |
- |
- |
013 1件: 13 💬 |
721 |
Evobrutinib |
Evobrutinib |
- |
- |
- |
013 3件: 13, 46, 49 💬 |
722 |
Evobrutinib 10mg |
Evobrutinib |
- |
- |
- |
013 1件: 13 💬 |
723 |
Evobrutinib 25mg |
Evobrutinib |
- |
- |
- |
013 1件: 13 💬 |
724 |
Exelon |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
725 |
Exelon transdermales pflaster |
- |
- |
- |
- |
013 1件: 13 💬 |
726 |
Experimental glatiramer acetate |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
727 |
Exposure to one or more disease-modifying drug(s)(dmds) used to treat ms |
- |
- |
- |
- |
013 1件: 13 💬 |
728 |
Extavia |
- |
- |
- |
- |
013 1件: 13 💬 |
729 |
Extavia (interferon beta-1b), novartis pharma ag |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
730 |
Extavia 250 microgram/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
731 |
Extavia 250 micrograms/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
732 |
Extavia*sc 15fl 250mcg/ml+15si |
- |
- |
- |
- |
013 1件: 13 💬 |
733 |
Extavia® |
- |
- |
- |
- |
013 1件: 13 💬 |
734 |
Extended release fampridine |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
735 |
Extended-release oxycodone |
Oxycodone |
3件: D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
736 |
Extended-release quetiapine fumarate |
Quetiapine |
2件: D00458 D00458, D08456 D08456 💬 |
DRD2 2件: DRD2, HTR2A 💬 |
Alcoholism 11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway |
013 1件: 13 💬 |
737 |
F-18 fedaa1106 (bay85-8101) |
- |
- |
- |
- |
013 1件: 13 💬 |
738 |
Famciclovir |
Famciclovir |
1件: D00317 D00317 💬 |
- |
- |
013 1件: 13 💬 |
739 |
Fampridina |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
740 |
Fampridine |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 2件: 13, 14 💬 |
741 |
Fampridine sr |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
742 |
Fampridine-sr |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
743 |
Fampridine-sr b.i.d. (twice daily) |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
744 |
Fampyra |
- |
- |
- |
- |
013 2件: 13, 14 💬 |
745 |
Fampyra - 10 mg - compressa a rilascio prolungato - uso orale - flacone (hdpe) 56 compresse (4 flaconi da 14) |
- |
- |
- |
- |
013 1件: 13 💬 |
746 |
Fampyra 10 mg prolonged-release tablets |
- |
- |
- |
- |
013 1件: 13 💬 |
747 |
Fampyra 10mg prolonged release tablets |
- |
- |
- |
- |
013 1件: 13 💬 |
748 |
Fatigue |
- |
- |
- |
- |
013 1件: 13 💬 |
749 |
Febuxostat |
Febuxostat |
1件: D01206 D01206 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
002 3件: 2 , 6 , 13 💬 |
750 |
Fecal microbial transplant (fmt) |
- |
- |
- |
- |
013 1件: 13 💬 |
751 |
Fecal microbial transplants |
- |
- |
- |
- |
013 1件: 13 💬 |
752 |
Fecal microbiota |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
753 |
Femoston 1/10 |
- |
- |
- |
- |
013 1件: 13 💬 |
754 |
Femoston 2/10 |
- |
- |
- |
- |
013 1件: 13 💬 |
755 |
Fenebrutinib |
Fenebrutinib |
1件: D11457 D11457 💬 |
BTK 1件: BTK 💬 |
B cell receptor signaling pathway 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency |
013 1件: 13 💬 |
756 |
Feraheme |
- |
- |
- |
- |
013 1件: 13 💬 |
757 |
Ferumoxytol |
Ferumoxytol |
1件: D04177 D04177 💬 |
- |
- |
013 1件: 13 💬 |
758 |
Filgrastim |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 27件: 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
759 |
Fingolimob (fty) |
- |
- |
- |
- |
013 1件: 13 💬 |
760 |
Fingolimod |
Fingolimod |
1件: D10001 D10001 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 3件: 13, 14, 156 💬 |
761 |
Fingolimod (fty720) |
Fingolimod |
1件: D10001 D10001 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 2件: 13, 156 💬 |
762 |
Fingolimod 0.5 mg |
Fingolimod |
1件: D10001 D10001 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
763 |
Fingolimod 1.25 mg |
Fingolimod |
1件: D10001 D10001 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
764 |
Fingolimod hydrochloride |
Fingolimod |
1件: D10001 D10001 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 2件: 13, 14 💬 |
765 |
Fingolimodi |
- |
- |
- |
- |
013 1件: 13 💬 |
766 |
Fingolmod |
- |
- |
- |
- |
013 1件: 13 💬 |
767 |
Firategrast |
Firategrast |
1件: D06590 D06590 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
768 |
Firategrast (usan approved name) |
Firategrast |
1件: D06590 D06590 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
769 |
Firategrast 150 mg |
Firategrast |
1件: D06590 D06590 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
770 |
Firategrast 300 mg |
Firategrast |
1件: D06590 D06590 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
771 |
Firategrast gastro-retentive solution |
Firategrast |
1件: D06590 D06590 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
772 |
Firategrast immediate release tablet |
Firategrast |
1件: D06590 D06590 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
773 |
Firategrast modified release tablet |
Firategrast |
1件: D06590 D06590 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
774 |
Fish oil |
Fish oil |
- |
- |
- |
013 7件: 13, 46, 49, 66, 96, 260, 299 💬 |
775 |
Fish oil concentrate |
Fish oil |
- |
- |
- |
013 1件: 13 💬 |
776 |
Fish oil, rich in omega-3-acids |
Fish oil |
- |
- |
- |
013 1件: 13 💬 |
777 |
Fish oil,rich in omega 3 acids |
Fish oil |
- |
- |
- |
013 1件: 13 💬 |
778 |
Fludara |
- |
- |
- |
- |
013 1件: 13 💬 |
779 |
Fludarabine |
Fludarabine |
2件: D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
780 |
Flumazenil |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 5件: 6 , 13, 17, 18, 206 💬 |
781 |
Fluoxetin |
Fluoxetine |
2件: D00326 D00326, D00823 D00823 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
013 3件: 13, 179, 206 💬 |
782 |
Fluoxetin hexal |
Fluoxetine |
2件: D00326 D00326, D00823 D00823 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
013 1件: 13 💬 |
783 |
Fluoxetine |
Fluoxetine |
2件: D00326 D00326, D00823 D00823 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
013 4件: 13, 17, 78, 86 💬 |
784 |
Fluoxetine hydrochloride |
Fluoxetine |
2件: D00326 D00326, D00823 D00823 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
013 1件: 13 💬 |
785 |
Flupirtin |
- |
- |
- |
- |
013 1件: 13 💬 |
786 |
Flupirtine |
Flupirtine |
1件: D07978 D07978 💬 |
- |
- |
013 1件: 13 💬 |
787 |
Flupirtinmaleat |
- |
- |
- |
- |
013 1件: 13 💬 |
788 |
Flurbiprofen |
Flurbiprofen |
3件: D00330 D00330, D01475 D01475, D02290 D02290 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 3件: 13, 21, 46 💬 |
789 |
Fmp30 donor stool |
- |
- |
- |
- |
013 1件: 13 💬 |
790 |
Folate |
Folic acid |
1件: D00070 D00070 💬 |
- |
- |
013 3件: 13, 46, 49 💬 |
791 |
Folatescan (technetium tc 99mec20) |
- |
- |
- |
- |
013 4件: 13, 46, 49, 96 💬 |
792 |
Formistin |
- |
- |
- |
- |
013 1件: 13 💬 |
793 |
Formistin - 10 mg compresse rivestite con film 20 compresse |
- |
- |
- |
- |
013 1件: 13 💬 |
794 |
Formistin 10 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
795 |
Formulation a |
- |
- |
- |
- |
013 1件: 13 💬 |
796 |
Formulation b |
- |
- |
- |
- |
013 1件: 13 💬 |
797 |
Formulation c |
- |
- |
- |
- |
013 1件: 13 💬 |
798 |
Formulation d |
- |
- |
- |
- |
013 1件: 13 💬 |
799 |
Fpc |
- |
- |
- |
- |
013 1件: 13 💬 |
800 |
Freshly-pressed extra virgin olive oil |
Olea europaea leaf |
1件: D03311 D03311 💬 |
- |
- |
013 1件: 13 💬 |
801 |
Fty720 |
- |
- |
- |
- |
013 2件: 13, 14 💬 |
802 |
Fty720d |
- |
- |
- |
- |
013 1件: 13 💬 |
803 |
Full spectrum vitamin |
- |
- |
- |
- |
013 1件: 13 💬 |
804 |
Fully humanized anti-human il-6 receptor (il-6r) neutralizing monoclonal antibody |
- |
- |
- |
- |
013 1件: 13 💬 |
805 |
Fumaric acid |
Fumaric Acid |
1件: D02308 D02308 💬 |
- |
- |
013 1件: 13 💬 |
806 |
G-csf |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 16件: 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
807 |
G2-sfm (ifn-beta-1a from clone 484-39,fbs-free process) |
- |
- |
- |
- |
013 1件: 13 💬 |
808 |
Ga |
- |
- |
- |
- |
013 1件: 13 💬 |
809 |
Ga 20 mg/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
810 |
Ga 40 mg/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
811 |
Ga depot |
- |
- |
- |
- |
013 1件: 13 💬 |
812 |
Ga depot 40 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
813 |
Ga depot 40mg once monthly |
- |
- |
- |
- |
013 1件: 13 💬 |
814 |
Ga depot 80 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
815 |
Gabapentin |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 5件: 6 , 13, 19, 70, 298 💬 |
816 |
Gabapentine |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
013 1件: 13 💬 |
817 |
Gabapentine 300mg |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
013 1件: 13 💬 |
818 |
Gadobenate |
Gadobenic acid |
2件: D04283 D04283, D08018 D08018 💬 |
- |
- |
013 1件: 13 💬 |
819 |
Gadobenate dimeglumine |
Gadobenic acid |
2件: D04283 D04283, D08018 D08018 💬 |
- |
- |
013 1件: 13 💬 |
820 |
Gadobutrol |
Gadobutrol |
1件: D07420 D07420 💬 |
- |
- |
013 3件: 13, 22, 46 💬 |
821 |
Gadolinium |
Gadolinium |
- |
- |
- |
013 6件: 13, 34, 46, 58, 65, 86 💬 |
822 |
Gadolinium-based contrast |
Gadolinium |
- |
- |
- |
013 1件: 13 💬 |
823 |
Gadopentetate |
Gadopentetic acid |
2件: D01707 D01707, D08006 D08006 💬 |
- |
- |
013 2件: 13, 34 💬 |
824 |
Gadoteric acid |
Gadoteric acid |
1件: D08007 D08007 💬 |
- |
- |
013 1件: 13 💬 |
825 |
Gadoteridol |
Gadoteridol |
1件: D01137 D01137 💬 |
- |
- |
013 1件: 13 💬 |
826 |
Gadovist |
- |
- |
- |
- |
013 2件: 13, 22 💬 |
827 |
Gadovist 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado |
- |
- |
- |
- |
013 1件: 13 💬 |
828 |
Gadovist 1.0 mmol/ml injektionslösung |
- |
- |
- |
- |
013 1件: 13 💬 |
829 |
Gamma-tocopherol |
Tocopherol |
1件: D02332 D02332 💬 |
- |
- |
013 1件: 13 💬 |
830 |
Gbp |
- |
- |
- |
- |
013 1件: 13 💬 |
831 |
Gdc-0853 ro7010939 |
- |
- |
- |
- |
013 3件: 13, 46, 49 💬 |
832 |
Genotropin |
- |
- |
- |
- |
013 4件: 13, 78, 187, 193 💬 |
833 |
Gilenya |
- |
- |
- |
- |
002 3件: 2 , 13, 14 💬 |
834 |
Gilenya / imusera |
- |
- |
- |
- |
013 1件: 13 💬 |
835 |
Gilenya 0,5 mg hartkapseln |
- |
- |
- |
- |
013 1件: 13 💬 |
836 |
Gilenya® |
- |
- |
- |
- |
013 1件: 13 💬 |
837 |
Gileyna |
- |
- |
- |
- |
013 1件: 13 💬 |
838 |
Ginkgo |
Ginkgo biloba |
- |
- |
- |
006 4件: 6 , 13, 18, 90 💬 |
839 |
Ginkgo biloba |
Ginkgo biloba |
- |
- |
- |
013 3件: 13, 18, 90 💬 |
840 |
Ginseng |
Ginseng |
1件: D06772 D06772 💬 |
- |
- |
013 3件: 13, 46, 53 💬 |
841 |
Gla |
- |
- |
- |
- |
013 2件: 13, 19 💬 |
842 |
Glatiramer |
Glatiramer |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
002 4件: 2 , 13, 96, 156 💬 |
843 |
Glatiramer acetate |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 3件: 13, 96, 156 💬 |
844 |
Glatiramer acetate (copaxone®) |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 2件: 13, 156 💬 |
845 |
Glatiramer acetate (db) |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
846 |
Glatiramer acetate (ga) |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
847 |
Glatiramer acetate (ga) 40 mg |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
848 |
Glatiramer acetate (gtr) |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
849 |
Glatiramer acetate (ol) |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
850 |
Glatiramer acetate 150mg enteric coated tablets |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
851 |
Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
852 |
Glatiramer acetate 20 mg |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
853 |
Glatiramer acetate 20 mg, with mitoxantrone |
Acetate |
3件: D02166 D02166, D04318 D04318, D08224 D08224 💬 |
HLA-A 22件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, TOP2A, TOP2B 💬 |
Allograft rejection 33件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Platinum drug resistance, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
854 |
Glatiramer acetate 20 mg/0.5 ml |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
855 |
Glatiramer acetate 40 mg |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
856 |
Glatiramer acetate [ga] |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
857 |
Glatiramer acetate injection with oral cetirizine hydrochloride |
Acetate |
3件: D00664 D00664, D04318 D04318, D07662 D07662 💬 |
HLA-A 21件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, HRH1 💬 |
Allograft rejection 35件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Calcium signaling pathway, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
858 |
Glatiramer acetate with minocycline |
Acetate |
3件: D00850 D00850, D04318 D04318, D05045 D05045 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
859 |
Glatiramer acetate, (copaxone®) |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
860 |
Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
861 |
Glatiramer acetate, n-acetylcysteine |
Acetate |
2件: D00221 D00221, D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
862 |
Glatiramer acetato |
Glatiramer |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
863 |
Glatiramero acetato |
- |
- |
- |
- |
013 1件: 13 💬 |
864 |
Glicerol-1,3-didecanoato-2-octadeca-(6z,9z,12z)-trienoato |
- |
- |
- |
- |
013 1件: 13 💬 |
865 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 15件: 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
866 |
Glutamate and aspartate |
- |
- |
- |
- |
013 1件: 13 💬 |
867 |
Glycerol |
Glycerin |
1件: D00028 D00028 💬 |
- |
- |
006 5件: 6 , 13, 79, 316, 317 💬 |
868 |
Glycerol-1,3-didecanoate-2-octadeca-(6z,9z,12z)-trienoate |
Glycerin |
1件: D00028 D00028 💬 |
- |
- |
013 1件: 13 💬 |
869 |
Gnbac1 |
- |
- |
- |
- |
013 1件: 13 💬 |
870 |
Gnbac1 monoclonal antibody |
- |
- |
- |
- |
013 1件: 13 💬 |
871 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
872 |
Gold nanocrystals |
- |
- |
- |
- |
002 3件: 2 , 6 , 13 💬 |
873 |
Granulocyte-colony stimulating factor (g-csf) and prednisone |
Filgrastim |
2件: D00473 D00473, D03235 D03235 💬 |
CSF3R 2件: CSF3R, NR3C1 💬 |
Cytokine-cytokine receptor interaction 6件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer |
013 1件: 13 💬 |
874 |
Growth hormone |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 12件: 2 , 13, 19, 46, 78, 96, 187, 191, 193, 195, 265, 299 💬 |
875 |
Gsk1223249 |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
876 |
Gsk1841157 |
- |
- |
- |
- |
013 3件: 13, 35, 46 💬 |
877 |
Gsk2018682 |
- |
- |
- |
- |
013 1件: 13 💬 |
878 |
Gsk2018682 cd2 capsule |
- |
- |
- |
- |
013 1件: 13 💬 |
879 |
Gsk2018682 cd3 micronised tablet |
- |
- |
- |
- |
013 1件: 13 💬 |
880 |
Gsk2018682 cd3 non-micronised tablet |
- |
- |
- |
- |
013 1件: 13 💬 |
881 |
Gsk2018682 cd3 non-micronised tablet in fed state |
- |
- |
- |
- |
013 1件: 13 💬 |
882 |
Gsk239512 |
- |
- |
- |
- |
013 1件: 13 💬 |
883 |
Gsk2395612 |
- |
- |
- |
- |
013 1件: 13 💬 |
884 |
Gtr |
- |
- |
- |
- |
013 1件: 13 💬 |
885 |
Gtr.ace |
- |
- |
- |
- |
013 1件: 13 💬 |
886 |
Guanabenz |
Guanabenz |
1件: D04375 D04375 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 2件: 2 , 13 💬 |
887 |
Gw-1000-02 |
- |
- |
- |
- |
013 1件: 13 💬 |
888 |
Gylenia |
- |
- |
- |
- |
013 1件: 13 💬 |
889 |
Gylenia 0,5 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
890 |
Gz402668 |
- |
- |
- |
- |
013 1件: 13 💬 |
891 |
Gz402673 |
- |
- |
- |
- |
013 1件: 13 💬 |
892 |
H.p. acthar gel (repository corticotropin injection) |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 1件: 13 💬 |
893 |
H5g1.1-mab |
- |
- |
- |
- |
013 3件: 13, 50, 62 💬 |
894 |
Hbm9161 injection |
- |
- |
- |
- |
013 1件: 13 💬 |
895 |
Helminth ova |
- |
- |
- |
- |
013 1件: 13 💬 |
896 |
Hematopoetic stem cell infusion |
- |
- |
- |
- |
013 1件: 13 💬 |
897 |
Hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 12件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
898 |
Hidrocloruro de fingolimod |
Fingolimod |
1件: D10001 D10001 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 2件: 13, 14 💬 |
899 |
High dose aspirin (1300 mg/day) |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
900 |
High/low sodium diet |
- |
- |
- |
- |
013 1件: 13 💬 |
901 |
Histamine |
Histamine |
1件: D08040 D08040 💬 |
HRH1 4件: HRH1, HRH2, HRH3, HRH4 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
902 |
Histidine |
Histidine |
1件: D00032 D00032 💬 |
- |
- |
013 3件: 13, 169, 170 💬 |
903 |
Hmr 1726d |
- |
- |
- |
- |
013 1件: 13 💬 |
904 |
Hmr1726 |
- |
- |
- |
- |
013 1件: 13 💬 |
905 |
Hmr1726d |
- |
- |
- |
- |
013 1件: 13 💬 |
906 |
Hookworm larvae |
- |
- |
- |
- |
013 1件: 13 💬 |
907 |
Hp184 |
- |
- |
- |
- |
013 1件: 13 💬 |
908 |
Hul001 |
- |
- |
- |
- |
013 1件: 13 💬 |
909 |
Human anti-il-12 igg1 mab |
- |
- |
- |
- |
013 1件: 13 💬 |
910 |
Human anti-il-12 mab |
- |
- |
- |
- |
013 1件: 13 💬 |
911 |
Human anti-lingo-1 monoclonal antibody |
- |
- |
- |
- |
013 1件: 13 💬 |
912 |
Human autologous mesenchymal stem cells |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
913 |
Human fetal-derived neural stem cells (hnscs) |
- |
- |
- |
- |
013 1件: 13 💬 |
914 |
Human interferon beta |
Human interferon beta |
- |
- |
- |
013 2件: 13, 26 💬 |
915 |
Human interferon beta 1a (rebif) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
916 |
Human interferon beta-1a and glatiramer acetate |
Acetate |
2件: D04318 D04318, D04554 D04554 💬 |
HLA-A 22件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, IFNAR1, IFNAR2 💬 |
Allograft rejection 44件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
917 |
Human leucocyte interferon-alpha |
- |
- |
- |
- |
013 1件: 13 💬 |
918 |
Human monoclonal antibody (cnto 1275) to interleukin-12p40 |
- |
- |
- |
- |
013 1件: 13 💬 |
919 |
Human neural stem cells |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
920 |
Human normal immunoglobulin |
Human immunoglobulin G |
- |
- |
- |
011 9件: 11, 13, 14, 43, 45, 50, 51, 63, 65 💬 |
921 |
Human recombinant growth hormone |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
013 2件: 13, 299 💬 |
922 |
Human umbilical cord mesenchymal stem cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
013 2件: 13, 113 💬 |
923 |
Humax-cd20 |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 2件: 13, 46 💬 |
924 |
Hydrochlorothiazide |
Hydrochlorothiazide |
1件: D00340 D00340 💬 |
- |
- |
013 4件: 13, 67, 225, 235 💬 |
925 |
Hydrogen |
Hydrogen |
- |
- |
- |
005 7件: 5 , 6 , 13, 17, 83, 97, 226 💬 |
926 |
Hydrogen peroxide |
Hydrogen |
1件: D00008 D00008 💬 |
- |
- |
013 1件: 13 💬 |
927 |
Hydroxychloroquine |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
013 23件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
928 |
Hydroxytyrosol |
Hydroxytyrosol |
- |
- |
- |
013 1件: 13 💬 |
929 |
Hydroxyurea |
Hydroxyurea |
1件: D00341 D00341 💬 |
RRM2 1件: RRM2 💬 |
Drug metabolism - other enzymes 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway |
003 8件: 3 , 13, 19, 20, 65, 85, 86, 284 💬 |
930 |
Hyperimmune caprine serum against hiv lysate |
- |
- |
- |
- |
013 1件: 13 💬 |
931 |
Ibudilast |
Ibudilast |
1件: D01385 D01385 💬 |
CYSLTR1 8件: CYSLTR1, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PTGIR 💬 |
Apelin signaling pathway 16件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 2件: 2 , 13 💬 |
932 |
Ibuprofen |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 6件: 13, 46, 65, 113, 271, 299 💬 |
933 |
Ibuprofen sandoz 400 mg filmtabletten |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
934 |
Idebenone |
Idebenone |
1件: D01750 D01750 💬 |
- |
- |
006 5件: 6 , 13, 18, 113, 302 💬 |
935 |
Ifa incomplete freund's adjuvant |
- |
- |
- |
- |
013 1件: 13 💬 |
936 |
Ifn beta 1a 44 mcg tiw |
- |
- |
- |
- |
013 1件: 13 💬 |
937 |
Ifn beta-1a |
- |
- |
- |
- |
013 1件: 13 💬 |
938 |
Ifn ß-1a |
- |
- |
- |
- |
013 1件: 13 💬 |
939 |
Ifn-beta-1a (rebif®) |
- |
- |
- |
- |
013 1件: 13 💬 |
940 |
Ifn-beta-1a, (avonex®) |
- |
- |
- |
- |
013 1件: 13 💬 |
941 |
Ifn-ß-1a (rebif®) |
- |
- |
- |
- |
013 1件: 13 💬 |
942 |
Ifn-ß-1a, (avonex®) |
- |
- |
- |
- |
013 1件: 13 💬 |
943 |
Il2 |
- |
- |
- |
- |
013 2件: 13, 60 💬 |
944 |
Imatinib |
Imatinib |
2件: D01441 D01441, D08066 D08066 💬 |
ABL1 3件: ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
945 |
Imatinib mesilate |
Imatinib |
2件: D01441 D01441, D08066 D08066 💬 |
ABL1 3件: ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 3件: 13, 86, 88 💬 |
946 |
Imatinib mesylate |
Imatinib |
2件: D01441 D01441, D08066 D08066 💬 |
ABL1 3件: ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 5件: 13, 28, 34, 51, 86 💬 |
947 |
Immune globulin |
- |
- |
- |
- |
011 3件: 11, 13, 14 💬 |
948 |
Immune globulin iv [human], 10% caprylate/chromatography purified |
- |
- |
- |
- |
013 1件: 13 💬 |
949 |
Immunoglobulin |
- |
- |
- |
- |
013 3件: 13, 14, 63 💬 |
950 |
Immunoglobulin g |
- |
- |
- |
- |
011 7件: 11, 13, 14, 49, 50, 63, 65 💬 |
951 |
Immunosuppressive agents |
- |
- |
- |
- |
013 2件: 13, 50 💬 |
952 |
Impact |
- |
- |
- |
- |
006 8件: 6 , 13, 46, 50, 53, 96, 97, 299 💬 |
953 |
Imu-838 |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
954 |
Imu-838 (30 mg/day) |
- |
- |
- |
- |
013 1件: 13 💬 |
955 |
Imu-838 (45 mg/day) |
- |
- |
- |
- |
013 1件: 13 💬 |
956 |
Imurel |
- |
- |
- |
- |
013 4件: 13, 46, 96, 97 💬 |
957 |
Incabotulinumtoxina |
- |
- |
- |
- |
013 1件: 13 💬 |
958 |
Incobotulinum toxin a |
- |
- |
- |
- |
002 3件: 2 , 6 , 13 💬 |
959 |
Inebilizumab |
Inebilizumab |
1件: D11757 D11757 💬 |
CD19 1件: CD19 💬 |
B cell receptor signaling pathway 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency |
011 3件: 11, 13, 300 💬 |
960 |
Inf beta-1a |
- |
- |
- |
- |
013 1件: 13 💬 |
961 |
Influenza vaccine |
- |
- |
- |
- |
011 5件: 11, 13, 46, 51, 84 💬 |
962 |
Inhaled cannabis |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
963 |
Injectable ms dmt |
- |
- |
- |
- |
013 1件: 13 💬 |
964 |
Injection of autologous stem cells |
- |
- |
- |
- |
013 1件: 13 💬 |
965 |
Injection of cell free media |
- |
- |
- |
- |
013 1件: 13 💬 |
966 |
Inn colecalciferol |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 1件: 13 💬 |
967 |
Inosine |
Inosine |
1件: D00054 D00054 💬 |
- |
- |
002 4件: 2 , 6 , 13, 17 💬 |
968 |
Insulin |
- |
- |
- |
- |
013 5件: 13, 46, 75, 78, 299 💬 |
969 |
Int131 |
- |
- |
- |
- |
013 1件: 13 💬 |
970 |
Interferon beta |
Human interferon beta |
- |
- |
- |
013 5件: 13, 20, 26, 96, 97 💬 |
971 |
Interferon beta - 1a (ifn) |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
972 |
Interferon beta -1b |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
973 |
Interferon beta 1 |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
974 |
Interferon beta 1-a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
975 |
Interferon beta 1-b (betaferon/betaseron, bay86-5046) |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
976 |
Interferon beta 1a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
977 |
Interferon beta 1a 30 ug im once weekly |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
978 |
Interferon beta 1a pegilado |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
979 |
Interferon beta 1a, oral doxycycline |
Doxycycline |
6件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D04554 D04554, D07876 D07876 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
980 |
Interferon beta 1b |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
981 |
Interferon beta 1b (betaseron, bay86-5046) |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
982 |
Interferon beta therapy |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
983 |
Interferon beta treatment to add-on atorvastatin treatment |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
984 |
Interferon beta type 1a |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
985 |
Interferon beta-1 a |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
986 |
Interferon beta-1a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 4件: 13, 26, 96, 97 💬 |
987 |
Interferon beta-1a (avonex) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
988 |
Interferon beta-1a (avonex®) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
989 |
Interferon beta-1a (current approved manufacturing process invloving fbs) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
990 |
Interferon beta-1a (new process, manufactured without fbs) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
991 |
Interferon beta-1a (rebif) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
992 |
Interferon beta-1a (rebif®) alone |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
993 |
Interferon beta-1a 30 µg |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
994 |
Interferon beta-1a fbs-free/hsa free, rnf |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
995 |
Interferon beta-1a fbs-free/hsa-free |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
996 |
Interferon beta-1a fbs-free/hsa-free, rnf |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
997 |
Interferon beta-1a hsa+ biosimilar |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
998 |
Interferon beta-1a hsa-free biosimilar |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
999 |
Interferon beta-1a original |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1000 |
Interferon beta-1a, 30 µg/0.5 ml |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1001 |
Interferon beta-1b |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1002 |
Interferon beta-1b (betaferon, bay 86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1003 |
Interferon beta-1b (betaferon, bay86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1004 |
Interferon beta-1b (betaferon/betaseron, bay86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1005 |
Interferon beta-1b (betaferon®, bay 86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1006 |
Interferon beta-1b (betaseron, bay86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1007 |
Interferon beta-1b (betaseron, betaferon, bay86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1008 |
Interferon beta-1b (pf530, betaferon) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1009 |
Interferon beta-1b and tacrolimus |
Human interferon beta |
3件: D00107 D00107, D00746 D00746, D08556 D08556 💬 |
IFNAR1 7件: IFNAR1, IFNAR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 47件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Epstein-Barr virus infection, Glucagon signaling pathway, Glutamatergic synapse, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
1010 |
Interferon beta-1b group |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1011 |
Interferon beta-1b, (betaseron bay86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1012 |
Interferon beta-1b, frp about 6 weeks after randomization |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1013 |
Interferon beta-1b, frp within 15 days after randomization |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1014 |
Interferon beta-1b/atorvastatin group |
Atorvastatin |
4件: D00258 D00258, D00746 D00746, D00887 D00887, D07474 D07474 💬 |
HMGCR 3件: HMGCR, IFNAR1, IFNAR2 💬 |
AMPK signaling pathway 22件: AMPK signaling pathway, Bile secretion, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Terpenoid backbone biosynthesis, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1015 |
Interferon beta1a |
- |
- |
- |
- |
013 1件: 13 💬 |
1016 |
Interferon ß-1a |
- |
- |
- |
- |
013 1件: 13 💬 |
1017 |
Interferon ß-1a (avonex®) |
- |
- |
- |
- |
013 1件: 13 💬 |
1018 |
Interferon ß-1a 30 µg |
- |
- |
- |
- |
013 1件: 13 💬 |
1019 |
Interferon ß-1b |
- |
- |
- |
- |
013 1件: 13 💬 |
1020 |
Interferon-1beta (betaseron, bay86-5046) |
- |
- |
- |
- |
013 1件: 13 💬 |
1021 |
Interferon-beta |
Human interferon beta |
- |
- |
- |
013 2件: 13, 97 💬 |
1022 |
Interferon-beta (ifn-beta) |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
1023 |
Interferon-beta 1a |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
1024 |
Interferon-beta 1a fbs-free/hsa free, rnf |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
1025 |
Interferon-beta 1a fbs-free/hsa-free, rnf |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
1026 |
Interferon-beta 1b |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
1027 |
Interferon-beta 1b (betaseron) |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
1028 |
Interferon-beta [ifn-beta] |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
1029 |
Interferon-beta and human leukocyte interferon-a |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
1030 |
Interferon-beta-1 |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
1031 |
Interferon-beta-1a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 2件: 13, 97 💬 |
1032 |
Interferon-beta-1a (avonex) plus methylprednisolone |
Human interferon beta |
7件: D00407 D00407, D00751 D00751, D00979 D00979, D04554 D04554, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
IFNAR1 3件: IFNAR1, IFNAR2, NR3C1 💬 |
Coronavirus disease - COVID-19 19件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1033 |
Interferon-beta-1a fbs-free/hsa free, rnf |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1034 |
Interferon-beta-1a fbs-free/hsa-free |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1035 |
Interferon-beta-1b |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1036 |
Interferon-beta-1b (betaseron, bay 86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1037 |
Interferon-beta1 |
- |
- |
- |
- |
013 1件: 13 💬 |
1038 |
Interferon-ß |
- |
- |
- |
- |
013 1件: 13 💬 |
1039 |
Interferon-ß [ifn-ß] |
- |
- |
- |
- |
013 1件: 13 💬 |
1040 |
Interferon-ß-1 |
- |
- |
- |
- |
013 1件: 13 💬 |
1041 |
Interferon-ß-1a |
- |
- |
- |
- |
013 1件: 13 💬 |
1042 |
Interferon-ß-1b |
- |
- |
- |
- |
013 1件: 13 💬 |
1043 |
Interferone |
- |
- |
- |
- |
013 1件: 13 💬 |
1044 |
Interferón beta 1a |
- |
- |
- |
- |
013 1件: 13 💬 |
1045 |
Interferón beta 1a pegilado |
- |
- |
- |
- |
013 1件: 13 💬 |
1046 |
Interferón beta-1a pegilado |
- |
- |
- |
- |
013 1件: 13 💬 |
1047 |
Intradetrusor injection of botulinum toxin-a |
- |
- |
- |
- |
013 1件: 13 💬 |
1048 |
Intratect |
- |
- |
- |
- |
013 3件: 13, 35, 65 💬 |
1049 |
Intrathecal administration of autologous msc-np |
- |
- |
- |
- |
013 1件: 13 💬 |
1050 |
Intrathecal methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
013 1件: 13 💬 |
1051 |
Intrathecal msc-np injection |
- |
- |
- |
- |
013 1件: 13 💬 |
1052 |
Intravenous (iv) infusions |
- |
- |
- |
- |
013 1件: 13 💬 |
1053 |
Intravenous immunoglobulin |
- |
- |
- |
- |
013 8件: 13, 14, 35, 38, 39, 49, 51, 309 💬 |
1054 |
Intravenous injection of mesenchymal stem cells |
- |
- |
- |
- |
013 1件: 13 💬 |
1055 |
Intravenous methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 2件: 13, 145 💬 |
1056 |
Intravenous steroid |
- |
- |
- |
- |
013 1件: 13 💬 |
1057 |
Ipx056 |
- |
- |
- |
- |
013 1件: 13 💬 |
1058 |
Ipx056 10 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1059 |
Ipx056 20 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1060 |
Ipx056 30 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1061 |
Ipx056 35 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1062 |
Ipx056 40 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1063 |
Ipx056-10 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1064 |
Ipx056-20 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1065 |
Ipx056-25 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1066 |
Ipx056-30 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1067 |
Ipx056-35 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1068 |
Ipx056-40 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1069 |
Ir902 |
- |
- |
- |
- |
013 1件: 13 💬 |
1070 |
Iron oxide |
Ferric oxide |
1件: D04168 D04168 💬 |
- |
- |
013 1件: 13 💬 |
1071 |
Isentress |
- |
- |
- |
- |
013 1件: 13 💬 |
1072 |
Isoxsuprine |
Isoxsuprine |
1件: D08092 D08092 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
1073 |
Isoxsuprine hydrochloride |
Isoxsuprine |
1件: D08092 D08092 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
1074 |
Iv methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
1075 |
Iv methylprednisolone (steroids) |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
1076 |
Ivig |
Human immunoglobulin G |
- |
- |
- |
011 8件: 11, 13, 14, 17, 35, 50, 51, 65 💬 |
1077 |
Ixazomib |
Ixazomib |
1件: D10130 D10130 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
013 3件: 13, 16, 28 💬 |
1078 |
Ixazomib (ninlaro®) capsules |
Ixazomib |
1件: D10130 D10130 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
013 1件: 13 💬 |
1079 |
Jm |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
1080 |
Jm-4 |
- |
- |
- |
- |
013 1件: 13 💬 |
1081 |
Kemstro |
- |
- |
- |
- |
013 1件: 13 💬 |
1082 |
Kepivance |
- |
- |
- |
- |
013 1件: 13 💬 |
1083 |
Keppra |
- |
- |
- |
- |
013 1件: 13 💬 |
1084 |
Keppra 250mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1085 |
Keppra 500mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1086 |
Keppra ® |
- |
- |
- |
- |
013 1件: 13 💬 |
1087 |
Ketamine |
Ketamine |
2件: D00711 D00711, D08098 D08098 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 5件: 13, 70, 113, 156, 215 💬 |
1088 |
Ketoconazole |
Ketoconazole |
1件: D00351 D00351 💬 |
CYP17A1 1件: CYP17A1 💬 |
Cortisol synthesis and secretion 6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis |
008 3件: 8 , 13, 75 💬 |
1089 |
Keyhole limpet hemocyanin |
keyhole limpet hemocyanin |
- |
- |
- |
013 2件: 13, 46 💬 |
1090 |
Keyhole limpet hemocyanin (klh) |
keyhole limpet hemocyanin |
- |
- |
- |
013 1件: 13 💬 |
1091 |
Keyhole limpet hemocyanin (klh) neo-antigen |
keyhole limpet hemocyanin |
- |
- |
- |
013 1件: 13 💬 |
1092 |
Klh |
- |
- |
- |
- |
013 2件: 13, 65 💬 |
1093 |
L acetyl carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 1件: 13 💬 |
1094 |
L-000124467 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
1095 |
L-carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 6件: 13, 96, 97, 265, 298, 316 💬 |
1096 |
L-histidine |
Histidine |
1件: D00032 D00032 💬 |
- |
- |
013 1件: 13 💬 |
1097 |
L01bb04 |
- |
- |
- |
- |
013 1件: 13 💬 |
1098 |
L03 ab |
- |
- |
- |
- |
013 1件: 13 💬 |
1099 |
L03 ab 08 |
- |
- |
- |
- |
013 1件: 13 💬 |
1100 |
L03 ab07 |
- |
- |
- |
- |
013 1件: 13 💬 |
1101 |
L03ab13 |
- |
- |
- |
- |
013 1件: 13 💬 |
1102 |
L04aa04 |
- |
- |
- |
- |
013 1件: 13 💬 |
1103 |
L04aa04 - immunoglobulina antitimocitaria (di coniglio) immunoglobulina di coniglio antitimociti umani thymoglobuline |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 1件: 13 💬 |
1104 |
L04aa31 |
- |
- |
- |
- |
013 1件: 13 💬 |
1105 |
La |
- |
- |
- |
- |
006 5件: 6 , 13, 75, 76, 222 💬 |
1106 |
Lactose |
Lactose |
2件: D00046 D00046, D03226 D03226 💬 |
- |
- |
002 6件: 2 , 6 , 13, 97, 228, 310 💬 |
1107 |
Lactose monohydrate |
Lactose |
2件: D00046 D00046, D03226 D03226 💬 |
- |
- |
013 1件: 13 💬 |
1108 |
Lamotrigine |
Lamotrigine |
1件: D00354 D00354 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 5件: 13, 34, 38, 114, 144 💬 |
1109 |
Lamotrigine extended release tablets |
Lamotrigine |
1件: D00354 D00354 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 1件: 13 💬 |
1110 |
Laquinimod |
Laquinimod |
- |
- |
- |
008 4件: 8 , 13, 49, 96 💬 |
1111 |
Laquinimod 0.3 |
Laquinimod |
- |
- |
- |
013 1件: 13 💬 |
1112 |
Laquinimod 0.6 |
Laquinimod |
- |
- |
- |
013 1件: 13 💬 |
1113 |
Laquinimod 1.2 |
Laquinimod |
- |
- |
- |
013 1件: 13 💬 |
1114 |
Laquinimod capsulas 0.6 mg |
Laquinimod |
- |
- |
- |
013 1件: 13 💬 |
1115 |
Laquinimod capsules 0.3 mg |
Laquinimod |
- |
- |
- |
013 1件: 13 💬 |
1116 |
Laquinimod capsules 0.6 mg |
Laquinimod |
- |
- |
- |
013 1件: 13 💬 |
1117 |
Laquinimod sodium (usan) |
Laquinimod |
- |
- |
- |
013 1件: 13 💬 |
1118 |
Laquinimod tablets 0.3 mg |
Laquinimod |
- |
- |
- |
013 1件: 13 💬 |
1119 |
Lemtrada |
- |
- |
- |
- |
013 2件: 13, 65 💬 |
1120 |
Lemtrada 12 mg konzentrat zur herstellung einer infusionslösung |
- |
- |
- |
- |
013 1件: 13 💬 |
1121 |
Lenograstim |
Lenograstim |
1件: D03247 D03247 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 7件: 2 , 13, 16, 18, 19, 57, 65 💬 |
1122 |
Levetiracetam |
Levetiracetam |
1件: D00709 D00709 💬 |
SV2A 1件: SV2A 💬 |
ECM-receptor interaction 1件: ECM-receptor interaction |
002 4件: 2 , 4 , 6 , 13 💬 |
1123 |
Levitra |
- |
- |
- |
- |
013 2件: 13, 86 💬 |
1124 |
Levocarnil |
- |
- |
- |
- |
013 1件: 13 💬 |
1125 |
Levofolene |
Levoleucovorin |
1件: D04715 D04715 💬 |
- |
- |
013 1件: 13 💬 |
1126 |
Levofolene 4 mg 30 cpr |
Levoleucovorin |
1件: D04715 D04715 💬 |
- |
- |
013 1件: 13 💬 |
1127 |
Levonorgestrel |
Levonorgestrel |
1件: D00950 D00950 💬 |
PGR 1件: PGR 💬 |
Breast cancer 4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 1件: 13 💬 |
1128 |
Lfb-r603 |
- |
- |
- |
- |
013 1件: 13 💬 |
1129 |
Lfb-r603, tgtx1101 |
- |
- |
- |
- |
013 1件: 13 💬 |
1130 |
Lidocaine |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 10件: 6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬 |
1131 |
Lidocaine patch 5% |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 1件: 13 💬 |
1132 |
Linoleic acid |
Linoleic acid |
- |
- |
- |
013 2件: 13, 299 💬 |
1133 |
Linoleic acid/oleic acid |
Linoleic acid |
1件: D02315 D02315 💬 |
- |
- |
013 1件: 13 💬 |
1134 |
Liofen xl |
- |
- |
- |
- |
013 1件: 13 💬 |
1135 |
Liothyronine |
Liothyronine |
2件: D01011 D01011, D08128 D08128 💬 |
THRA 2件: THRA, THRB 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
013 3件: 13, 210, 212 💬 |
1136 |
Liothyronine sodium |
Liothyronine |
2件: D01011 D01011, D08128 D08128 💬 |
THRA 2件: THRA, THRB 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
013 1件: 13 💬 |
1137 |
Lipoic acid |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
002 5件: 2 , 5 , 13, 14, 20 💬 |
1138 |
Lipoic acid (la) with fish oil and la without fish oil |
Fish oil |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
013 1件: 13 💬 |
1139 |
Lipoic acid and omega-3 fatty acids |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
013 1件: 13 💬 |
1140 |
Lisdexamfetamine |
Lisdexamfetamine |
1件: D08130 D08130 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 1件: 13 💬 |
1141 |
Lisdexamfetamine sulfate |
Lisdexamfetamine |
1件: D08130 D08130 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 1件: 13 💬 |
1142 |
Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field |
- |
- |
- |
- |
013 1件: 13 💬 |
1143 |
Lithium carbonate |
Carbonate ion |
1件: D00801 D00801 💬 |
- |
- |
002 6件: 2 , 13, 17, 18, 19, 127 💬 |
1144 |
Live hookworm larvae |
- |
- |
- |
- |
013 1件: 13 💬 |
1145 |
Live necator americanus larvae |
- |
- |
- |
- |
013 1件: 13 💬 |
1146 |
Locally approved intravenous contrast medium for contrast enhanced mri |
- |
- |
- |
- |
013 1件: 13 💬 |
1147 |
Loperamide |
Loperamide |
3件: D00729 D00729, D07113 D07113, D08144 D08144 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
013 2件: 13, 97 💬 |
1148 |
Loratadine |
Loratadine |
1件: D00364 D00364 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 3件: 13, 46, 98 💬 |
1149 |
Low dose arm receiving neutral oil and 400 iu/g of vitamin d every second day |
Vitamin D |
- |
- |
- |
013 1件: 13 💬 |
1150 |
Low dose aspirin (162 mg/day) |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
1151 |
Low dose cannabis |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
1152 |
Low immunogenic interferon-beta-1a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1153 |
Lubiprostone |
Lubiprostone |
1件: D04790 D04790 💬 |
CLCN2 1件: CLCN2 💬 |
Mineral absorption 1件: Mineral absorption |
006 4件: 6 , 13, 290, 299 💬 |
1154 |
Lumbar puncture |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
1155 |
Lutenyl |
- |
- |
- |
- |
013 1件: 13 💬 |
1156 |
Ly2127399 |
- |
- |
- |
- |
013 3件: 13, 46, 49 💬 |
1157 |
Ly248686 |
- |
- |
- |
- |
013 1件: 13 💬 |
1158 |
Lysine |
L-Lysine |
1件: D02304 D02304 💬 |
- |
- |
013 4件: 13, 97, 228, 299 💬 |
1159 |
M2951 |
- |
- |
- |
- |
013 3件: 13, 46, 49 💬 |
1160 |
Mabcampath |
- |
- |
- |
- |
013 2件: 13, 60 💬 |
1161 |
Mabcampath 10 mg/ml concentrado para solución para perfusión |
- |
- |
- |
- |
013 1件: 13 💬 |
1162 |
Mabcampath ® |
- |
- |
- |
- |
013 1件: 13 💬 |
1163 |
Mabcampath-1h |
- |
- |
- |
- |
013 1件: 13 💬 |
1164 |
Mabcampath® |
- |
- |
- |
- |
013 1件: 13 💬 |
1165 |
Mabthera |
- |
- |
- |
- |
011 22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
1166 |
Mabthera (rituximab) |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 4件: 13, 46, 49, 53 💬 |
1167 |
Mabthera or biosimilar rituximab product |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1168 |
Mabthera® |
- |
- |
- |
- |
013 6件: 13, 35, 43, 44, 46, 93 💬 |
1169 |
Magnesium |
Magnesium |
- |
- |
- |
006 16件: 6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
1170 |
Maltodextrin |
Maltodextrin |
1件: D02329 D02329 💬 |
- |
- |
006 4件: 6 , 13, 96, 97 💬 |
1171 |
Maltodextrin fiber supplement |
Maltodextrin |
1件: D02329 D02329 💬 |
- |
- |
013 1件: 13 💬 |
1172 |
Mangafodipir |
Mangafodipir |
1件: D08262 D08262 💬 |
- |
- |
013 2件: 13, 58 💬 |
1173 |
Mangafodipir (teslascan) |
Mangafodipir |
1件: D08262 D08262 💬 |
- |
- |
013 1件: 13 💬 |
1174 |
Mannose |
Mannose |
- |
- |
- |
013 2件: 13, 256 💬 |
1175 |
Mantadan*20cpr 100mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1176 |
Marijuana |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
1177 |
Masitinb mesylate |
- |
- |
- |
- |
013 1件: 13 💬 |
1178 |
Masitinib |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
1179 |
Masitinib mesylate |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
1180 |
Mastinib |
- |
- |
- |
- |
013 1件: 13 💬 |
1181 |
Mavenclad |
- |
- |
- |
- |
013 1件: 13 💬 |
1182 |
Mavenclad 10 mg tablets |
- |
- |
- |
- |
013 1件: 13 💬 |
1183 |
Mavenclad tabletter 10 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1184 |
Mavenclad® |
- |
- |
- |
- |
013 1件: 13 💬 |
1185 |
Mayzent |
- |
- |
- |
- |
013 1件: 13 💬 |
1186 |
Mbp peptide |
- |
- |
- |
- |
013 1件: 13 💬 |
1187 |
Mbp8298 |
- |
- |
- |
- |
013 1件: 13 💬 |
1188 |
Mbp8298 synthetic peptide |
- |
- |
- |
- |
013 1件: 13 💬 |
1189 |
Md1003 |
- |
- |
- |
- |
002 5件: 2 , 10, 13, 14, 20 💬 |
1190 |
Md1003 100mg capsule |
- |
- |
- |
- |
013 1件: 13 💬 |
1191 |
Medi-551 |
- |
- |
- |
- |
013 2件: 13, 51 💬 |
1192 |
Medi-551 100 mg-iv |
- |
- |
- |
- |
013 1件: 13 💬 |
1193 |
Medi-551 30 mg-iv |
- |
- |
- |
- |
013 1件: 13 💬 |
1194 |
Medi-551 300 mg-sc |
- |
- |
- |
- |
013 1件: 13 💬 |
1195 |
Medi-551 60 mg-sc |
- |
- |
- |
- |
013 1件: 13 💬 |
1196 |
Medi-551 600 mg-iv |
- |
- |
- |
- |
013 1件: 13 💬 |
1197 |
Medical marijuana |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
1198 |
Medrol |
- |
- |
- |
- |
013 3件: 13, 46, 222 💬 |
1199 |
Megadose oral methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
1200 |
Melatonin |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
006 11件: 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
1201 |
Melphalan |
Melphalan |
1件: D00369 D00369 💬 |
- |
- |
011 15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
1202 |
Memantine |
Memantine |
2件: D04905 D04905, D08174 D08174 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 7件: 2 , 6 , 8 , 13, 49, 127, 205 💬 |
1203 |
Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent) |
- |
- |
- |
- |
013 1件: 13 💬 |
1204 |
Menitorix |
- |
- |
- |
- |
013 1件: 13 💬 |
1205 |
Mesenchymal stem cells |
- |
- |
- |
- |
002 11件: 2 , 6 , 13, 20, 49, 51, 60, 96, 222, 274, 299 💬 |
1206 |
Mesenchymal stem cells (mscs) |
- |
- |
- |
- |
013 3件: 13, 36, 96 💬 |
1207 |
Mesenchymal stem/stromal cells |
- |
- |
- |
- |
013 1件: 13 💬 |
1208 |
Mesna |
- |
- |
- |
- |
011 11件: 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬 |
1209 |
Metex |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
1210 |
Metformin |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
1211 |
Methelphenidate |
- |
- |
- |
- |
013 1件: 13 💬 |
1212 |
Methotrexat |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
013 4件: 13, 46, 50, 96 💬 |
1213 |
Methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
1214 |
Methyl b12 |
- |
- |
- |
- |
013 1件: 13 💬 |
1215 |
Methyl folate |
Folic acid |
1件: D00070 D00070 💬 |
- |
- |
013 1件: 13 💬 |
1216 |
Methyl prednisolonate |
- |
- |
- |
- |
013 1件: 13 💬 |
1217 |
Methyloprednisolone |
- |
- |
- |
- |
013 1件: 13 💬 |
1218 |
Methylphenidate |
Methylphenidate |
2件: D01296 D01296, D04999 D04999 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 7件: 6 , 13, 34, 84, 113, 179, 206 💬 |
1219 |
Methylphenidate hydrochloride |
Methylphenidate |
2件: D01296 D01296, D04999 D04999 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 2件: 6 , 13 💬 |
1220 |
Methylphenidate modified release |
Methylphenidate |
2件: D01296 D01296, D04999 D04999 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 1件: 13 💬 |
1221 |
Methylphenidate modified release 20 mg |
Methylphenidate |
2件: D01296 D01296, D04999 D04999 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 1件: 13 💬 |
1222 |
Methylphenidate modified release 30 mg |
Methylphenidate |
2件: D01296 D01296, D04999 D04999 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 1件: 13 💬 |
1223 |
Methylphenidate modified release 40 mg |
Methylphenidate |
2件: D01296 D01296, D04999 D04999 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 1件: 13 💬 |
1224 |
Methylprednisolon |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 4件: 13, 14, 51, 66 💬 |
1225 |
Methylprednisolon-21-hydrogensuccinat, natriumsalz |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
1226 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
1227 |
Methylprednisolone (drug) |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
1228 |
Methylprednisolone 1250 mg/24h x3 days |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
1229 |
Methylprednisolone hemisuccinate |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
1230 |
Methylprednisolone iv |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
1231 |
Methylprednisolone po |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
1232 |
Methylprednisolone sodium hemisuccinate |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 2件: 13, 97 💬 |
1233 |
Methylprednisolone sodium succinate |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 6件: 13, 46, 49, 50, 51, 211 💬 |
1234 |
Metilprednisolone sodio succinato |
- |
- |
- |
- |
013 2件: 13, 14 💬 |
1235 |
Mg |
- |
- |
- |
- |
006 3件: 6 , 13, 51 💬 |
1236 |
Microgynon |
- |
- |
- |
- |
013 2件: 13, 51 💬 |
1237 |
Microgynon® |
- |
- |
- |
- |
013 1件: 13 💬 |
1238 |
Micropirin |
- |
- |
- |
- |
013 1件: 13 💬 |
1239 |
Midazolam |
Midazolam |
3件: D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 11件: 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
1240 |
Mild dose cannabis |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
1241 |
Mineral boost (magnesium) |
Magnesium |
- |
- |
- |
013 1件: 13 💬 |
1242 |
Minocycline |
Minocycline |
2件: D00850 D00850, D05045 D05045 💬 |
- |
- |
002 13件: 2 , 6 , 8 , 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
1243 |
Minocycline 100 mg film-coated tablets |
Minocycline |
2件: D00850 D00850, D05045 D05045 💬 |
- |
- |
013 1件: 13 💬 |
1244 |
Minocycline 100mg |
Minocycline |
2件: D00850 D00850, D05045 D05045 💬 |
- |
- |
013 1件: 13 💬 |
1245 |
Minocycline hydrochloride |
Minocycline |
2件: D00850 D00850, D05045 D05045 💬 |
- |
- |
013 4件: 13, 201, 206, 299 💬 |
1246 |
Mirabegron |
Mirabegron |
1件: D09535 D09535 💬 |
ADRB3 1件: ADRB3 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway |
006 3件: 6 , 13, 226 💬 |
1247 |
Mis416 |
- |
- |
- |
- |
013 1件: 13 💬 |
1248 |
Mitoq |
- |
- |
- |
- |
006 3件: 6 , 13, 97 💬 |
1249 |
Mitoquinone |
Mitoquinone |
- |
- |
- |
013 1件: 13 💬 |
1250 |
Mitoxantrone |
Mitoxantrone |
2件: D02166 D02166, D08224 D08224 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
013 1件: 13 💬 |
1251 |
Mk0812 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
1252 |
Mln1202 |
- |
- |
- |
- |
013 1件: 13 💬 |
1253 |
Mmf |
- |
- |
- |
- |
013 13件: 13, 35, 40, 49, 50, 51, 60, 65, 66, 222, 224, 226, 299 💬 |
1254 |
Modafinil |
Modafinil |
1件: D01832 D01832 💬 |
- |
- |
006 4件: 6 , 13, 49, 93 💬 |
1255 |
Mog peptide |
- |
- |
- |
- |
013 1件: 13 💬 |
1256 |
Monitor |
Methamidophos |
- |
- |
- |
002 18件: 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
1257 |
Monoclonal antibody m-t412 |
- |
- |
- |
- |
013 1件: 13 💬 |
1258 |
Monomethyl fumarate |
Monomethyl fumarate |
1件: D11492 D11492 💬 |
- |
- |
013 1件: 13 💬 |
1259 |
Monomethyl fumarate 190 mg |
Monomethyl fumarate |
1件: D11492 D11492 💬 |
- |
- |
013 1件: 13 💬 |
1260 |
Montelukast |
Montelukast |
2件: D00529 D00529, D08229 D08229 💬 |
CYSLTR1 1件: CYSLTR1 💬 |
Calcium signaling pathway 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction |
013 5件: 13, 46, 85, 98, 228 💬 |
1261 |
Mor103 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
1262 |
Msc2015 |
- |
- |
- |
- |
013 1件: 13 💬 |
1263 |
Msc2304479a |
- |
- |
- |
- |
013 1件: 13 💬 |
1264 |
Msc2304480a |
- |
- |
- |
- |
013 1件: 13 💬 |
1265 |
Msc2304481a |
- |
- |
- |
- |
013 1件: 13 💬 |
1266 |
Msc2304482a |
- |
- |
- |
- |
013 1件: 13 💬 |
1267 |
Msc2358825a |
- |
- |
- |
- |
013 1件: 13 💬 |
1268 |
Msc2364447c |
- |
- |
- |
- |
013 2件: 13, 49 💬 |
1269 |
Msc2430913a or ono-4641 (to be used as synonyms) |
- |
- |
- |
- |
013 1件: 13 💬 |
1270 |
Msc2491529a |
- |
- |
- |
- |
013 1件: 13 💬 |
1271 |
Msdmds other than betaseron (interferon beta-1b, bay86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1272 |
Mstc-001 (ms-stat) |
- |
- |
- |
- |
013 1件: 13 💬 |
1273 |
Mt-1303 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
1274 |
Mt-1303 [0.1] |
- |
- |
- |
- |
013 1件: 13 💬 |
1275 |
Mt-1303 [0.2] |
- |
- |
- |
- |
013 1件: 13 💬 |
1276 |
Mt-1303 [0.4] |
- |
- |
- |
- |
013 1件: 13 💬 |
1277 |
Mt-1303-forma |
- |
- |
- |
- |
013 1件: 13 💬 |
1278 |
Mt-1303-formb |
- |
- |
- |
- |
013 1件: 13 💬 |
1279 |
Mt-1303-high |
- |
- |
- |
- |
013 1件: 13 💬 |
1280 |
Mt-1303-low |
- |
- |
- |
- |
013 1件: 13 💬 |
1281 |
Mt-1303-middle |
- |
- |
- |
- |
013 1件: 13 💬 |
1282 |
Multiferon |
- |
- |
- |
- |
013 1件: 13 💬 |
1283 |
Multiple (4 autologous subcutaneous t cell vaccinations with t cell lines reactive to nine myelin peptides) |
- |
- |
- |
- |
013 1件: 13 💬 |
1284 |
Mutagrip |
- |
- |
- |
- |
011 2件: 11, 13 💬 |
1285 |
Mycophenolate |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
1286 |
Mycophenolate mofetil |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 32件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
1287 |
Mycophenolate mofetil (cellcept) |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
011 2件: 11, 13 💬 |
1288 |
Mycophenolate mofetil (mmf) |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
013 7件: 13, 49, 51, 60, 65, 66, 222 💬 |
1289 |
Méthylprednisolone |
- |
- |
- |
- |
013 1件: 13 💬 |
1290 |
Méthylprednisolone mylan |
- |
- |
- |
- |
013 1件: 13 💬 |
1291 |
N acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
013 1件: 13 💬 |
1292 |
N-acetyl cysteine |
Cysteine |
2件: D00026 D00026, D02326 D02326 💬 |
- |
- |
013 7件: 13, 19, 34, 85, 88, 296, 310 💬 |
1293 |
N-acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 10件: 6 , 13, 19, 20, 49, 58, 85, 111, 164, 299 💬 |
1294 |
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine |
- |
- |
- |
- |
013 1件: 13 💬 |
1295 |
N.a. |
- |
- |
- |
- |
003 10件: 3 , 6 , 8 , 13, 46, 96, 97, 240, 256, 271 💬 |
1296 |
N02bg10 |
- |
- |
- |
- |
013 1件: 13 💬 |
1297 |
N03ax12 |
- |
- |
- |
- |
013 1件: 13 💬 |
1298 |
N06dx01 |
- |
- |
- |
- |
013 1件: 13 💬 |
1299 |
Nabilone |
Nabilone |
1件: D05099 D05099 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 2件: 6 , 13 💬 |
1300 |
Nabiximols |
Nabiximols |
1件: D09317 D09317 💬 |
- |
- |
013 1件: 13 💬 |
1301 |
Nabiximols - sativex |
Nabiximols |
1件: D09317 D09317 💬 |
- |
- |
013 1件: 13 💬 |
1302 |
Naltrexone |
Naltrexone |
2件: D02095 D02095, D05113 D05113 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 12件: 6 , 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬 |
1303 |
Namisol |
- |
- |
- |
- |
013 2件: 13, 298 💬 |
1304 |
Nanocort |
- |
- |
- |
- |
013 3件: 13, 46, 97 💬 |
1305 |
Nanocurcumin |
- |
- |
- |
- |
013 2件: 13, 271 💬 |
1306 |
Naproxen |
Naproxen |
1件: D00118 D00118 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 3件: 13, 46, 271 💬 |
1307 |
Natalizumab |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 4件: 13, 15, 46, 96 💬 |
1308 |
Natalizumab (bg00002) |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
1309 |
Natalizumab (ntz) |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
1310 |
Natalizumab (tysabri) |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
1311 |
Natalizumab for iv infusion |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
1312 |
Natalizumab for subcutaneous injection |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
1313 |
Natalizumab injection [tysabri] |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
1314 |
Natalizumab iv |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
1315 |
Natalizumab sc |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
1316 |
Natalizumab treatment |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
1317 |
Nbi-5788 |
- |
- |
- |
- |
013 1件: 13 💬 |
1318 |
Nbt-nm108 (60 g/day) |
- |
- |
- |
- |
013 1件: 13 💬 |
1319 |
Nd |
- |
- |
- |
- |
013 4件: 13, 46, 51, 97 💬 |
1320 |
Nebido |
- |
- |
- |
- |
013 1件: 13 💬 |
1321 |
Nebido® testosterone undecanoate 1000 mg/4 ml solution for injection |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
013 1件: 13 💬 |
1322 |
Necator americanus |
- |
- |
- |
- |
013 1件: 13 💬 |
1323 |
Neorecormon |
- |
- |
- |
- |
013 2件: 13, 18 💬 |
1324 |
Neramexane |
Neramexane |
- |
- |
- |
013 1件: 13 💬 |
1325 |
Neramexane mesylate |
Neramexane |
- |
- |
- |
013 1件: 13 💬 |
1326 |
Nerispirdine |
Nerispirdine |
- |
- |
- |
013 1件: 13 💬 |
1327 |
Nerispirdine (hp184) |
Nerispirdine |
- |
- |
- |
013 1件: 13 💬 |
1328 |
Nerispirdine hydrochloride |
Nerispirdine |
- |
- |
- |
013 1件: 13 💬 |
1329 |
Neupogen |
- |
- |
- |
- |
013 4件: 13, 28, 51, 285 💬 |
1330 |
Neuroaspis plp10® |
- |
- |
- |
- |
013 1件: 13 💬 |
1331 |
Neurontin |
- |
- |
- |
- |
013 1件: 13 💬 |
1332 |
Neurontin 300 mg hard capsule |
- |
- |
- |
- |
013 1件: 13 💬 |
1333 |
Neurovax |
- |
- |
- |
- |
013 1件: 13 💬 |
1334 |
Neurovax 300ug/ml dose for im injection |
- |
- |
- |
- |
013 1件: 13 💬 |
1335 |
New formulation of rebif - human interferon beta-1a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1336 |
Niacinamide |
Nicotinamide |
1件: D00036 D00036 💬 |
- |
- |
005 4件: 5 , 6 , 13, 67 💬 |
1337 |
Ninlaro |
- |
- |
- |
- |
013 2件: 13, 61 💬 |
1338 |
Nitrofurantoin |
Nitrofurantoin |
1件: D00439 D00439 💬 |
- |
- |
013 1件: 13 💬 |
1339 |
Nivolumab |
Nivolumab |
1件: D10316 D10316 💬 |
PDCD1 1件: PDCD1 💬 |
Cell adhesion molecules 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
1340 |
Nomegestrol |
Nomegestrol |
1件: D07222 D07222 💬 |
PGR 1件: PGR 💬 |
Breast cancer 4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 1件: 13 💬 |
1341 |
Nomegestrol acetate |
Acetate |
2件: D07222 D07222, D08281 D08281 💬 |
PGR 1件: PGR 💬 |
Breast cancer 4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 1件: 13 💬 |
1342 |
Non-pegylated interferon |
- |
- |
- |
- |
013 1件: 13 💬 |
1343 |
Norethindrone |
Norethisterone |
2件: D00182 D00182, D00953 D00953 💬 |
PGR 1件: PGR 💬 |
Breast cancer 4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 4件: 13, 46, 49, 299 💬 |
1344 |
Normal saline for injection |
- |
- |
- |
- |
013 1件: 13 💬 |
1345 |
Novantrone |
- |
- |
- |
- |
013 1件: 13 💬 |
1346 |
Novantrone*inf 2mg/ml 5ml |
- |
- |
- |
- |
013 1件: 13 💬 |
1347 |
Novartis pharmaceuticals corporation |
- |
- |
- |
- |
013 1件: 13 💬 |
1348 |
Novatrex |
- |
- |
- |
- |
013 1件: 13 💬 |
1349 |
Npb-01 |
- |
- |
- |
- |
013 3件: 13, 14, 162 💬 |
1350 |
Nt-ko-003 |
- |
- |
- |
- |
013 1件: 13 💬 |
1351 |
Nu100 |
- |
- |
- |
- |
013 1件: 13 💬 |
1352 |
Null |
- |
- |
- |
- |
006 16件: 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
1353 |
Nurown (msc-ntf cells) |
- |
- |
- |
- |
013 1件: 13 💬 |
1354 |
Nvf233 |
- |
- |
- |
- |
013 1件: 13 💬 |
1355 |
Och-ncnp1 |
- |
- |
- |
- |
013 1件: 13 💬 |
1356 |
Oclelizumab |
- |
- |
- |
- |
013 1件: 13 💬 |
1357 |
Ocr |
- |
- |
- |
- |
013 1件: 13 💬 |
1358 |
Ocrelizumab |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 3件: 13, 46, 49 💬 |
1359 |
Ocrelizumab 300 mg |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1360 |
Ocrelizumab 300mg |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1361 |
Ocrelizumab 300mg /10ml |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1362 |
Ocrelizumab 300mg/10 ml |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1363 |
Ocrelizumab 300mg/10ml |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1364 |
Ocrelizumab 600 mg |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1365 |
Ocrelizumab at home |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1366 |
Ocrelizumab dose 1 |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1367 |
Ocrelizumab dose 2 and dose 3 |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1368 |
Ocrevus |
- |
- |
- |
- |
013 1件: 13 💬 |
1369 |
Ocrrelizumab 300 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1370 |
Octagam |
- |
- |
- |
- |
013 2件: 13, 65 💬 |
1371 |
Octagam 5% |
- |
- |
- |
- |
013 2件: 13, 65 💬 |
1372 |
Octagam 50 mg/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
1373 |
Ofatumumab |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 3件: 13, 35, 46 💬 |
1374 |
Ofatumumab 100 |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1375 |
Ofatumumab 300 |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1376 |
Ofatumumab 30mg |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1377 |
Ofatumumab 3mg |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1378 |
Ofatumumab 60mg |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1379 |
Ofatumumab 700 |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1380 |
Ofatumumab subcutaneous injection |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1381 |
Oleic acid |
Oleic Acid |
1件: D02315 D02315 💬 |
- |
- |
013 2件: 13, 299 💬 |
1382 |
Oleovit d3 14.400 iu/ml oral drops, solution |
- |
- |
- |
- |
013 1件: 13 💬 |
1383 |
Olesoxime (tro19622) |
TRO19622 |
- |
- |
- |
013 1件: 13 💬 |
1384 |
Olive |
Olea europaea leaf |
- |
- |
- |
013 3件: 13, 49, 53 💬 |
1385 |
Olive oil |
Olea europaea leaf |
1件: D03311 D03311 💬 |
- |
- |
013 3件: 13, 49, 53 💬 |
1386 |
Omb157 |
- |
- |
- |
- |
013 1件: 13 💬 |
1387 |
Omb157g |
- |
- |
- |
- |
013 1件: 13 💬 |
1388 |
Omega 3 |
- |
- |
- |
- |
013 2件: 13, 299 💬 |
1389 |
Omega 3 fatty acids |
Omega-3 fatty acids |
- |
- |
- |
013 1件: 13 💬 |
1390 |
Omega-3 |
Omega-3 fatty acids |
- |
- |
- |
013 7件: 13, 46, 49, 66, 79, 96, 299 💬 |
1391 |
Omega-3 fatty acids |
Omega-3 fatty acids |
- |
- |
- |
013 2件: 13, 79 💬 |
1392 |
Omeprazole |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 16件: 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
1393 |
Onabotulinumtoxina |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
006 3件: 6 , 13, 226 💬 |
1394 |
Ono-4641 |
- |
- |
- |
- |
013 1件: 13 💬 |
1395 |
Ono-4641/ msc2430913a |
- |
- |
- |
- |
013 1件: 13 💬 |
1396 |
Ono-4641/msc2430913a |
- |
- |
- |
- |
013 1件: 13 💬 |
1397 |
Opicinumab |
Opicinumab |
1件: D11767 D11767 💬 |
- |
- |
013 1件: 13 💬 |
1398 |
Oral corticosteroids |
- |
- |
- |
- |
013 3件: 13, 46, 97 💬 |
1399 |
Oral lipoic acid (la) |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
013 1件: 13 💬 |
1400 |
Oral methylprednisolone 625 mg/24h x3 days |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
1401 |
Oral thc |
- |
- |
- |
- |
013 1件: 13 💬 |
1402 |
Ory2001 |
- |
- |
- |
- |
013 1件: 13 💬 |
1403 |
Os440 |
- |
- |
- |
- |
013 1件: 13 💬 |
1404 |
Other analgesics and antipyretics |
- |
- |
- |
- |
013 1件: 13 💬 |
1405 |
Other disease-modifying therapy |
- |
- |
- |
- |
013 1件: 13 💬 |
1406 |
Other h1 antagonist |
- |
- |
- |
- |
013 1件: 13 💬 |
1407 |
Other nervous system drugs |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
1408 |
Other: anxiety |
- |
- |
- |
- |
013 1件: 13 💬 |
1409 |
Other: balance |
Isoxaflutole |
- |
- |
- |
006 3件: 6 , 13, 299 💬 |
1410 |
Other: balance exercises |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
1411 |
Other: balance trainer balance exercises |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
1412 |
Other: balance training |
Isoxaflutole |
- |
- |
- |
006 2件: 6 , 13 💬 |
1413 |
Other: berg balance scale |
Isoxaflutole |
- |
- |
- |
006 2件: 6 , 13 💬 |
1414 |
Other: caffeine |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
1415 |
Other: cardiopulmonary evaluation |
- |
- |
- |
- |
013 1件: 13 💬 |
1416 |
Other: cawthorne cooksey exercises |
- |
- |
- |
- |
013 1件: 13 💬 |
1417 |
Other: classic, progressive endurance training |
- |
- |
- |
- |
013 1件: 13 💬 |
1418 |
Other: coduse balance training and step square exercises |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
1419 |
Other: conventional balance training |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
1420 |
Other: core stability |
- |
- |
- |
- |
013 1件: 13 💬 |
1421 |
Other: determination of calcium intake by a dietician interview |
Calcium |
- |
- |
- |
013 2件: 13, 46 💬 |
1422 |
Other: dmt withdrawal |
- |
- |
- |
- |
013 1件: 13 💬 |
1423 |
Other: dual task performance |
- |
- |
- |
- |
013 1件: 13 💬 |
1424 |
Other: dynamic balance training |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
1425 |
Other: evaluation of degree chronic fatigue. |
- |
- |
- |
- |
013 1件: 13 💬 |
1426 |
Other: exercise intervention |
- |
- |
- |
- |
013 2件: 13, 18 💬 |
1427 |
Other: fatigue |
- |
- |
- |
- |
013 1件: 13 💬 |
1428 |
Other: fear of falling |
- |
- |
- |
- |
013 1件: 13 💬 |
1429 |
Other: fingolimod |
Fingolimod |
1件: D10001 D10001 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
1430 |
Other: four square step test |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
1431 |
Other: functional mobility |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
1432 |
Other: functional reach test |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
1433 |
Other: group balance training |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
1434 |
Other: histamine |
Histamine |
1件: D08040 D08040 💬 |
HRH1 4件: HRH1, HRH2, HRH3, HRH4 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
1435 |
Other: hydrogen peroxide |
Hydrogen |
1件: D00008 D00008 💬 |
- |
- |
013 1件: 13 💬 |
1436 |
Other: imaging |
- |
- |
- |
- |
013 1件: 13 💬 |
1437 |
Other: incontinence severity |
- |
- |
- |
- |
013 1件: 13 💬 |
1438 |
Other: intrathecal saline injection |
- |
- |
- |
- |
013 1件: 13 💬 |
1439 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 21件: 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
1440 |
Other: liberation therapy |
- |
- |
- |
- |
013 1件: 13 💬 |
1441 |
Other: mitoxantrone - immunomodulator |
Mitoxantrone |
2件: D02166 D02166, D08224 D08224 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
013 1件: 13 💬 |
1442 |
Other: modified paleolithic diet |
- |
- |
- |
- |
013 1件: 13 💬 |
1443 |
Other: mybetaapp |
- |
- |
- |
- |
013 1件: 13 💬 |
1444 |
Other: natalizumab |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
1445 |
Other: natalizumab discontinuation |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
1446 |
Other: nbt-nm108 (0 g/day) |
- |
- |
- |
- |
013 1件: 13 💬 |
1447 |
Other: neuromuscular evaluation |
- |
- |
- |
- |
013 1件: 13 💬 |
1448 |
Other: nintendo wii fit balance exercises |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
1449 |
Other: no device |
- |
- |
- |
- |
013 1件: 13 💬 |
1450 |
Other: no msdmds therapy (control) |
- |
- |
- |
- |
013 1件: 13 💬 |
1451 |
Other: no treatment arm |
- |
- |
- |
- |
013 1件: 13 💬 |
1452 |
Other: non impact aerobics |
- |
- |
- |
- |
013 1件: 13 💬 |
1453 |
Other: normal saline |
- |
- |
- |
- |
013 4件: 13, 222, 226, 280 💬 |
1454 |
Other: observation of ocrelizumab as treatment in rrms patients |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1455 |
Other: observational control |
- |
- |
- |
- |
013 1件: 13 💬 |
1456 |
Other: one-leg stance test |
- |
- |
- |
- |
013 1件: 13 💬 |
1457 |
Other: other: disease modifying therapies (dmt) |
- |
- |
- |
- |
013 1件: 13 💬 |
1458 |
Other: pain |
- |
- |
- |
- |
013 1件: 13 💬 |
1459 |
Other: passive : lecture series |
- |
- |
- |
- |
013 1件: 13 💬 |
1460 |
Other: peak |
- |
- |
- |
- |
013 1件: 13 💬 |
1461 |
Other: peanut butter |
Peanut |
- |
- |
- |
013 1件: 13 💬 |
1462 |
Other: periodized exercise training |
- |
- |
- |
- |
013 1件: 13 💬 |
1463 |
Other: plasticity-based computerized cognitive remediation program |
- |
- |
- |
- |
013 1件: 13 💬 |
1464 |
Other: pnf |
- |
- |
- |
- |
013 1件: 13 💬 |
1465 |
Other: position sense |
- |
- |
- |
- |
013 1件: 13 💬 |
1466 |
Other: progressive exercise |
- |
- |
- |
- |
013 1件: 13 💬 |
1467 |
Other: propensity score |
- |
- |
- |
- |
013 1件: 13 💬 |
1468 |
Other: psp |
- |
- |
- |
- |
013 1件: 13 💬 |
1469 |
Other: qalcimum questionnaire |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
1470 |
Other: questionnaires |
- |
- |
- |
- |
006 5件: 6 , 13, 41, 93, 96 💬 |
1471 |
Other: rhythmic auditory stimulation (ras) |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
1472 |
Other: specifically design 6 month resistance training program |
- |
- |
- |
- |
013 1件: 13 💬 |
1473 |
Other: spinning grp |
- |
- |
- |
- |
013 1件: 13 💬 |
1474 |
Other: standard of care |
- |
- |
- |
- |
013 7件: 13, 49, 64, 85, 96, 245, 246 💬 |
1475 |
Other: static balance test |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
1476 |
Other: strength training |
- |
- |
- |
- |
013 1件: 13 💬 |
1477 |
Other: supervised physical therapy |
- |
- |
- |
- |
013 1件: 13 💬 |
1478 |
Other: timed up an go test |
- |
- |
- |
- |
013 1件: 13 💬 |
1479 |
Other: training groupe |
- |
- |
- |
- |
013 1件: 13 💬 |
1480 |
Other: trunk impairment |
- |
- |
- |
- |
013 1件: 13 💬 |
1481 |
Other: trunk position sense |
- |
- |
- |
- |
013 1件: 13 💬 |
1482 |
Other: uspio mri - gadolinium mri |
Gadolinium |
- |
- |
- |
013 1件: 13 💬 |
1483 |
Other: vestibular habituation exercises |
- |
- |
- |
- |
013 1件: 13 💬 |
1484 |
Other: vestibular rehabilitation: balance and eye movement exercises |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
1485 |
Other: virtual reality group |
- |
- |
- |
- |
013 1件: 13 💬 |
1486 |
Other: vitamin k |
Phylloquinone |
1件: D00148 D00148 💬 |
- |
- |
013 1件: 13 💬 |
1487 |
Other: vitamin k cream |
Phylloquinone |
1件: D00148 D00148 💬 |
- |
- |
013 1件: 13 💬 |
1488 |
Other: withdrawal of dalfampridine-er 10mg |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
1489 |
Ovastat |
Treosulfan |
1件: D07253 D07253 💬 |
- |
- |
013 2件: 13, 65 💬 |
1490 |
Ovastat 1000 |
Treosulfan |
1件: D07253 D07253 💬 |
- |
- |
013 2件: 13, 65 💬 |
1491 |
Ovastat 5000 |
Treosulfan |
1件: D07253 D07253 💬 |
- |
- |
013 2件: 13, 65 💬 |
1492 |
Oxcarbazepine |
Oxcarbazepine |
1件: D00533 D00533 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 1件: 13 💬 |
1493 |
Oxine |
Oxyquinoline |
1件: D05321 D05321 💬 |
- |
- |
013 1件: 13 💬 |
1494 |
Oxybutynin |
Oxybutynin |
2件: D00465 D00465, D00722 D00722 💬 |
CHRM1 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 2件: 6 , 13 💬 |
1495 |
Oxybutynin hydrochloride |
Oxybutynin |
2件: D00465 D00465, D00722 D00722 💬 |
CHRM1 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 2件: 6 , 13 💬 |
1496 |
Oxycodone |
Oxycodone |
3件: D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 7件: 6 , 13, 46, 70, 226, 231, 298 💬 |
1497 |
Oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
006 18件: 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
1498 |
Ozanimod |
Ozanimod |
1件: D10968 D10968 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 3件: 13, 96, 97 💬 |
1499 |
Ozanimod 0.5 mg |
Ozanimod |
1件: D10968 D10968 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
1500 |
Ozanimod 1 mg |
Ozanimod |
1件: D10968 D10968 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
1501 |
Ozanimod hci |
Ozanimod |
1件: D10968 D10968 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
1502 |
Ozanimod hcl |
Ozanimod |
1件: D10968 D10968 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
1503 |
Ozanimod hydrochloride |
Ozanimod |
1件: D10968 D10968 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 3件: 13, 96, 97 💬 |
1504 |
Palifermin |
Palifermin |
1件: D05338 D05338 💬 |
FGFR2 1件: FGFR2 💬 |
Calcium signaling pathway 13件: Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells |
013 4件: 13, 38, 39, 65 💬 |
1505 |
Pantoprazole |
Pantoprazole |
2件: D02593 D02593, D05353 D05353 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 2件: 13, 65 💬 |
1506 |
Paracetamol |
Acetaminophen |
1件: D00217 D00217 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
003 5件: 3 , 6 , 13, 35, 46 💬 |
1507 |
Paracetamolo 500 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1508 |
Paroxetine |
Paroxetine |
4件: D02260 D02260, D02362 D02362, D05374 D05374, D05375 D05375 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 3件: 6 , 13, 46 💬 |
1509 |
Part a: 100 mg/ml gsk2618960 |
- |
- |
- |
- |
013 1件: 13 💬 |
1510 |
Part b: dose of gsk2618960 decided from part a |
- |
- |
- |
- |
013 1件: 13 💬 |
1511 |
Part c: dose of gsk2618960 decided from part a and b |
- |
- |
- |
- |
013 1件: 13 💬 |
1512 |
Pas |
- |
- |
- |
- |
013 1件: 13 💬 |
1513 |
Pat |
- |
- |
- |
- |
006 3件: 6 , 13, 160 💬 |
1514 |
Pb006 |
- |
- |
- |
- |
013 1件: 13 💬 |
1515 |
Pcv |
- |
- |
- |
- |
013 1件: 13 💬 |
1516 |
Peanut |
Peanut |
- |
- |
- |
013 1件: 13 💬 |
1517 |
Peg |
- |
- |
- |
- |
006 9件: 6 , 13, 46, 65, 78, 96, 97, 240, 299 💬 |
1518 |
Peg-liposomal prednisolone sodium phosphate |
Phosphate ion |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 2件: 13, 97 💬 |
1519 |
Peginterferon beta-1a |
Peginterferon beta-1a |
1件: D10483 D10483 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1520 |
Pegylated intereron beta-1a |
- |
- |
- |
- |
013 1件: 13 💬 |
1521 |
Pegylated interferon beta-1a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1522 |
Pending |
- |
- |
- |
- |
013 6件: 13, 19, 96, 97, 113, 302 💬 |
1523 |
Personalized extended interval dosing of natalizumab |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
1524 |
Pet with 11c-flumazenil |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
013 1件: 13 💬 |
1525 |
Pf-06342674 0.25 mg/kg |
- |
- |
- |
- |
013 1件: 13 💬 |
1526 |
Pf-06342674 1.5 mg/kg |
- |
- |
- |
- |
013 1件: 13 💬 |
1527 |
Pf-06342674 6.0 mg/kg |
- |
- |
- |
- |
013 1件: 13 💬 |
1528 |
Phenylcyclopropylamine derivatives and dual lsd1/mao-b (lysine-specific demethylase 1 and monoamine oxidase-b) inhibitor |
L-Lysine |
1件: D02304 D02304 💬 |
- |
- |
013 1件: 13 💬 |
1529 |
Phenytoin |
Phenytoin |
2件: D00512 D00512, D02103 D02103 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 1件: 13 💬 |
1530 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 30件: 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
1531 |
Pi-2301 |
- |
- |
- |
- |
013 1件: 13 💬 |
1532 |
Pioglitazone |
Pioglitazone |
2件: D00945 D00945, D08378 D08378 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
1533 |
Pixantrone |
Pixantrone |
1件: D05522 D05522 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
011 2件: 11, 13 💬 |
1534 |
Pl 04515/0127 |
- |
- |
- |
- |
013 1件: 13 💬 |
1535 |
Pl 12762/0049 |
- |
- |
- |
- |
013 1件: 13 💬 |
1536 |
Placebo |
- |
- |
- |
- |
003 26件: 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
1537 |
Platelet transfusion |
- |
- |
- |
- |
013 1件: 13 💬 |
1538 |
Platform |
- |
- |
- |
- |
013 1件: 13 💬 |
1539 |
Pledigry |
- |
- |
- |
- |
013 1件: 13 💬 |
1540 |
Plegridy |
- |
- |
- |
- |
013 1件: 13 💬 |
1541 |
Plegridy (peginterferon beta-1a), biogen idec ltd |
Peginterferon beta-1a |
1件: D10483 D10483 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1542 |
Plegridy - 125 mcg - soluzione iniettabile - uso sottocutaneo - penna preriempita - 0,5 ml - 6 penne preriempite |
- |
- |
- |
- |
013 1件: 13 💬 |
1543 |
Plegridy 125 micrograms |
- |
- |
- |
- |
013 1件: 13 💬 |
1544 |
Plegridy 63 micrograms |
- |
- |
- |
- |
013 1件: 13 💬 |
1545 |
Pleneva tm bgc20-0134 |
- |
- |
- |
- |
013 1件: 13 💬 |
1546 |
Plovamer acetate |
Acetate |
- |
- |
- |
013 1件: 13 💬 |
1547 |
Plovamer acetate 0.5 milligram (mg) |
Acetate |
- |
- |
- |
013 1件: 13 💬 |
1548 |
Plovamer acetate 10 mg |
Acetate |
- |
- |
- |
013 1件: 13 💬 |
1549 |
Plovamer acetate 20 mg |
Acetate |
- |
- |
- |
013 1件: 13 💬 |
1550 |
Plovamer acetate 3 mg |
Acetate |
- |
- |
- |
013 1件: 13 💬 |
1551 |
Plp |
- |
- |
- |
- |
013 1件: 13 💬 |
1552 |
Plp peptide |
- |
- |
- |
- |
013 1件: 13 💬 |
1553 |
Pneumovax ii |
- |
- |
- |
- |
013 1件: 13 💬 |
1554 |
Pnu-215062 sodium salt |
- |
- |
- |
- |
013 1件: 13 💬 |
1555 |
Po |
- |
- |
- |
- |
013 1件: 13 💬 |
1556 |
Polyphenon e |
- |
- |
- |
- |
013 2件: 13, 36 💬 |
1557 |
Ponesimod |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
1558 |
Ponesimod 10 mg |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
1559 |
Ponesimod 20 mg |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
1560 |
Ponesimod 40 mg |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
1561 |
Pravastatin |
Pravastatin |
2件: D00893 D00893, D08410 D08410 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬 |
1562 |
Prd806998 |
- |
- |
- |
- |
013 1件: 13 💬 |
1563 |
Prebiotics (prebiotin prebiotic fiber stick pac) |
- |
- |
- |
- |
013 1件: 13 💬 |
1564 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
1565 |
Prednisolone sodium phosphate |
Phosphate ion |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 2件: 13, 97 💬 |
1566 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
1567 |
Pregabalin |
Pregabalin |
1件: D02716 D02716 💬 |
CACNA2D1 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes 7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
013 5件: 13, 36, 46, 70, 298 💬 |
1568 |
Prepulsid |
- |
- |
- |
- |
013 1件: 13 💬 |
1569 |
Prn2246 |
- |
- |
- |
- |
013 1件: 13 💬 |
1570 |
Probiotics (visbiome®) |
- |
- |
- |
- |
013 1件: 13 💬 |
1571 |
Procedure: alcohol wipes vs. no alcohol wipes |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
013 1件: 13 💬 |
1572 |
Procedure: autologous bone marrow transplantation |
- |
- |
- |
- |
013 2件: 13, 28 💬 |
1573 |
Procedure: autologous hematopoietic stem cell transplant |
- |
- |
- |
- |
013 1件: 13 💬 |
1574 |
Procedure: autologous hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 6件: 11, 13, 14, 28, 49, 51 💬 |
1575 |
Procedure: autologous stem cell transplantation |
- |
- |
- |
- |
013 2件: 13, 28 💬 |
1576 |
Procedure: dynamic contrast-enhanced magnetic resonance imaging |
- |
- |
- |
- |
013 1件: 13 💬 |
1577 |
Procedure: exergame |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
1578 |
Procedure: fecal microbiota transplantation (fmt) of fmp30 donor stool |
- |
- |
- |
- |
013 1件: 13 💬 |
1579 |
Procedure: hematopoietic stem cell therapy |
- |
- |
- |
- |
013 1件: 13 💬 |
1580 |
Procedure: hematopoietic stem cell transplantation |
- |
- |
- |
- |
013 3件: 13, 65, 285 💬 |
1581 |
Procedure: hematopoietic stem cell transplantation (hsct) |
- |
- |
- |
- |
013 1件: 13 💬 |
1582 |
Procedure: home based balance training |
Isoxaflutole |
- |
- |
- |
006 2件: 6 , 13 💬 |
1583 |
Procedure: immunoadsorption |
- |
- |
- |
- |
013 1件: 13 💬 |
1584 |
Procedure: irradiation |
- |
- |
- |
- |
013 1件: 13 💬 |
1585 |
Procedure: lumbar puncture |
- |
- |
- |
- |
006 5件: 6 , 13, 19, 96, 97 💬 |
1586 |
Procedure: mri |
- |
- |
- |
- |
013 2件: 13, 78 💬 |
1587 |
Procedure: peripheral blood stem cell transplantation |
- |
- |
- |
- |
011 11件: 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285 💬 |
1588 |
Procedure: plasma exchange |
- |
- |
- |
- |
013 5件: 13, 43, 44, 64, 222 💬 |
1589 |
Procedure: radiation therapy |
- |
- |
- |
- |
013 3件: 13, 284, 285 💬 |
1590 |
Procedure: syngeneic bone marrow transplantation |
- |
- |
- |
- |
011 3件: 11, 13, 14 💬 |
1591 |
Procedure: warm compress prior to injection of glatiramer acetate |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
1592 |
Prohance (gadoteridol) |
Gadoteridol |
1件: D01137 D01137 💬 |
- |
- |
013 1件: 13 💬 |
1593 |
Prolonged-release fampridine |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
1594 |
Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis a, hepatitis b, tick-borne encephalitis, meningococcal, pneumococcal) |
- |
- |
- |
- |
013 1件: 13 💬 |
1595 |
Provigil |
- |
- |
- |
- |
013 1件: 13 💬 |
1596 |
Provigil (modafinil) |
Modafinil |
1件: D01832 D01832 💬 |
- |
- |
013 1件: 13 💬 |
1597 |
Prucalopride |
Prucalopride |
1件: D09205 D09205 💬 |
HTR4 1件: HTR4 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway |
013 3件: 13, 51, 96 💬 |
1598 |
Ptl201 |
- |
- |
- |
- |
013 1件: 13 💬 |
1599 |
Pv |
- |
- |
- |
- |
013 3件: 13, 97, 215 💬 |
1600 |
Quadrivalent influenza vaccine |
- |
- |
- |
- |
013 1件: 13 💬 |
1601 |
Quality of life |
- |
- |
- |
- |
013 1件: 13 💬 |
1602 |
Quetiapine |
Quetiapine |
2件: D00458 D00458, D08456 D08456 💬 |
DRD2 2件: DRD2, HTR2A 💬 |
Alcoholism 11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway |
006 2件: 6 , 13 💬 |
1603 |
Quinidina |
Quinidine |
4件: D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 1件: 13 💬 |
1604 |
Quinidina sulfato |
Quinidine |
4件: D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 1件: 13 💬 |
1605 |
Quinidine |
Quinidine |
4件: D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
002 3件: 2 , 8 , 13 💬 |
1606 |
Quinidine sulfate |
Quinidine |
4件: D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 1件: 13 💬 |
1607 |
R lipoic acid |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
013 1件: 13 💬 |
1608 |
Rabbit |
Rabbit |
- |
- |
- |
011 8件: 11, 13, 49, 51, 60, 65, 96, 285 💬 |
1609 |
Rabbit anti-human thymocyte immunoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 2件: 13, 96 💬 |
1610 |
Rabbit human t lymphocyte immunoglobulin |
Rabbit |
- |
- |
- |
013 2件: 13, 60 💬 |
1611 |
Radiation: gadopentetate dimeglumine |
Gadopentetic acid |
2件: D01707 D01707, D08006 D08006 💬 |
- |
- |
013 2件: 13, 34 💬 |
1612 |
Ralenova |
- |
- |
- |
- |
013 1件: 13 💬 |
1613 |
Raltegravir |
Raltegravir |
1件: D06676 D06676 💬 |
- |
- |
013 4件: 13, 26, 93, 265 💬 |
1614 |
Ramatroban |
Ramatroban |
1件: D01128 D01128 💬 |
PTGDR 2件: PTGDR, TBXA2R 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation |
013 1件: 13 💬 |
1615 |
Ranitidine |
Ranitidine |
2件: D00422 D00422, D00673 D00673 💬 |
HRH2 1件: HRH2 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction |
013 2件: 13, 65 💬 |
1616 |
Raptiva |
- |
- |
- |
- |
011 9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 💬 |
1617 |
Raptiva 100 mg/ml powder and solvent for solution for injection |
- |
- |
- |
- |
011 7件: 11, 13, 46, 53, 61, 95, 96 💬 |
1618 |
Ras |
- |
- |
- |
- |
006 3件: 6 , 13, 66 💬 |
1619 |
Ratg |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 3件: 13, 51, 60 💬 |
1620 |
Ravulizumab |
Ravulizumab |
1件: D11054 D11054 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
002 5件: 2 , 11, 13, 62, 109 💬 |
1621 |
Rc18 160 mg |
- |
- |
- |
- |
013 2件: 13, 53 💬 |
1622 |
Rc18 160mg |
- |
- |
- |
- |
011 3件: 11, 13, 66 💬 |
1623 |
Rc18 240mg |
- |
- |
- |
- |
013 2件: 13, 66 💬 |
1624 |
Rebif |
- |
- |
- |
- |
013 1件: 13 💬 |
1625 |
Rebif (ifn beta-1a subcutaneous three times per week) |
- |
- |
- |
- |
013 1件: 13 💬 |
1626 |
Rebif (ifn ß-1a subcutaneous three times per week) |
- |
- |
- |
- |
013 1件: 13 💬 |
1627 |
Rebif (interferon beta 1a) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1628 |
Rebif (interferon beta-1a) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1629 |
Rebif (interferon beta-1a), merck serono europe ltd |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1630 |
Rebif 22 |
- |
- |
- |
- |
013 1件: 13 💬 |
1631 |
Rebif 22 micrograms |
- |
- |
- |
- |
013 1件: 13 💬 |
1632 |
Rebif 22 y 44 mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
1633 |
Rebif 22® |
- |
- |
- |
- |
013 1件: 13 💬 |
1634 |
Rebif 44 |
- |
- |
- |
- |
013 1件: 13 💬 |
1635 |
Rebif 44 microgramos solución inyectable |
- |
- |
- |
- |
013 1件: 13 💬 |
1636 |
Rebif 44 microgramos solución inyectable en jeringa precargada |
- |
- |
- |
- |
013 1件: 13 💬 |
1637 |
Rebif 44 micrograms |
- |
- |
- |
- |
013 1件: 13 💬 |
1638 |
Rebif 44 micrograms solution for injection |
- |
- |
- |
- |
013 1件: 13 💬 |
1639 |
Rebif 44 micrograms solution for injection in pre-filled syringe |
- |
- |
- |
- |
013 1件: 13 💬 |
1640 |
Rebif 44 µg |
- |
- |
- |
- |
013 1件: 13 💬 |
1641 |
Rebif 44® |
- |
- |
- |
- |
013 1件: 13 💬 |
1642 |
Rebif 8,8 µg, rebif 22µg |
- |
- |
- |
- |
013 1件: 13 💬 |
1643 |
Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack |
- |
- |
- |
- |
013 1件: 13 💬 |
1644 |
Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack. |
- |
- |
- |
- |
013 1件: 13 💬 |
1645 |
Rebif new formulation + ibuprofen prn |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
1646 |
Rebif new formulation + prophylactic ibuprofen |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
1647 |
Rebif new formulation 44mcg multidose cartridge |
- |
- |
- |
- |
013 1件: 13 💬 |
1648 |
Rebif new formulation non titrated |
- |
- |
- |
- |
013 1件: 13 💬 |
1649 |
Rebif new formulation titrated |
- |
- |
- |
- |
013 1件: 13 💬 |
1650 |
Rebif sc 12sir 12000000ui44mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
1651 |
Rebif sc 12sir 6000000ui 22mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
1652 |
Rebif*sc 12sir 12000000ui44mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
1653 |
Rebif*sc 12sir 6000000ui 22mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
1654 |
Rebif® |
- |
- |
- |
- |
013 1件: 13 💬 |
1655 |
Rebif® (clone 484-39) |
- |
- |
- |
- |
013 1件: 13 💬 |
1656 |
Rebif® new formulation |
- |
- |
- |
- |
013 1件: 13 💬 |
1657 |
Rebif® new formulation (ifn-beta-1a, rnf) |
- |
- |
- |
- |
013 1件: 13 💬 |
1658 |
Rebif® new formulation (rnf) |
- |
- |
- |
- |
013 1件: 13 💬 |
1659 |
Rebif® new formulation (rnf) using rebismarttm |
- |
- |
- |
- |
013 1件: 13 💬 |
1660 |
Recombinant human alpha b-crystallin |
- |
- |
- |
- |
013 1件: 13 💬 |
1661 |
Recombinant human erythropoietin |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
013 1件: 13 💬 |
1662 |
Recombinant human ifn beta |
- |
- |
- |
- |
013 1件: 13 💬 |
1663 |
Recombinant human interferon beta |
Human interferon beta |
- |
- |
- |
013 1件: 13 💬 |
1664 |
Recombinant humanized anti-alpha 4 integrin antibody |
- |
- |
- |
- |
013 1件: 13 💬 |
1665 |
Recombinant interferon beta-1b |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1666 |
Repository corticotropin injection |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 5件: 2 , 13, 46, 84, 222 💬 |
1667 |
Revaxis |
- |
- |
- |
- |
013 1件: 13 💬 |
1668 |
Rg2077 (ctla4-igg4m) |
- |
- |
- |
- |
013 1件: 13 💬 |
1669 |
Rhb-104 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
1670 |
Rhepo |
- |
- |
- |
- |
013 1件: 13 💬 |
1671 |
Rhifn beta-1b |
- |
- |
- |
- |
013 1件: 13 💬 |
1672 |
Rhigf-1 (cep-151) |
- |
- |
- |
- |
013 1件: 13 💬 |
1673 |
Rhigm22 |
- |
- |
- |
- |
013 1件: 13 💬 |
1674 |
Rhumab 2h7 |
- |
- |
- |
- |
013 3件: 13, 46, 49 💬 |
1675 |
Rhumab to il-17a (igg1-k-class) |
- |
- |
- |
- |
013 4件: 13, 46, 56, 96 💬 |
1676 |
Rhumab to il-17a igg1-k-class |
- |
- |
- |
- |
013 1件: 13 💬 |
1677 |
Rhuph20 |
- |
- |
- |
- |
013 2件: 13, 14 💬 |
1678 |
Riboflavin |
Riboflavin |
3件: D00050 D00050, D01622 D01622, D01913 D01913 💬 |
- |
- |
013 8件: 13, 38, 46, 96, 97, 162, 168, 265 💬 |
1679 |
Rifampin |
Rifampicin |
1件: D00211 D00211 💬 |
- |
- |
006 5件: 6 , 13, 84, 86, 299 💬 |
1680 |
Rilutek |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
1681 |
Riluzole |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 8件: 2 , 3 , 5 , 8 , 13, 17, 18, 206 💬 |
1682 |
Ritalin |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
1683 |
Ritalin la 20mg capsules |
- |
- |
- |
- |
013 1件: 13 💬 |
1684 |
Ritalin la 30mg capsules |
- |
- |
- |
- |
013 1件: 13 💬 |
1685 |
Ritalin la 40mg capsules |
- |
- |
- |
- |
013 1件: 13 💬 |
1686 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
1687 |
Rituximab infusion |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 2件: 13, 222 💬 |
1688 |
Rituximab it |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1689 |
Rituximab iv |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1690 |
Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1691 |
Rivastigmin |
- |
- |
- |
- |
013 1件: 13 💬 |
1692 |
Rivastigmine |
Rivastigmine |
2件: D02558 D02558, D03822 D03822 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
005 3件: 5 , 6 , 13 💬 |
1693 |
Rivastigmine transdermal patch |
Rivastigmine |
2件: D02558 D02558, D03822 D03822 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
006 2件: 6 , 13 💬 |
1694 |
Rnf |
- |
- |
- |
- |
013 1件: 13 💬 |
1695 |
Rns60 |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
1696 |
Rns60 125 ml |
- |
- |
- |
- |
013 1件: 13 💬 |
1697 |
Rns60 250 ml |
- |
- |
- |
- |
013 1件: 13 💬 |
1698 |
Ro 496-4913/f03 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
1699 |
Ro 496-4913/f07 |
- |
- |
- |
- |
013 1件: 13 💬 |
1700 |
Ro0506997 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
1701 |
Ro4964913 |
- |
- |
- |
- |
013 1件: 13 💬 |
1702 |
Ro4964913 f07 |
- |
- |
- |
- |
013 1件: 13 💬 |
1703 |
Ro4964913/f03 |
- |
- |
- |
- |
013 1件: 13 💬 |
1704 |
Ro4964913/f07 |
- |
- |
- |
- |
013 1件: 13 💬 |
1705 |
Ro4964913/f07-01 |
- |
- |
- |
- |
013 1件: 13 💬 |
1706 |
Ro4964913/f07-01 (commercial) |
- |
- |
- |
- |
013 1件: 13 💬 |
1707 |
Ro4964913/f07-01 (development) |
- |
- |
- |
- |
013 1件: 13 💬 |
1708 |
Ro5333787 |
- |
- |
- |
- |
013 1件: 13 💬 |
1709 |
Ro7010939 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
1710 |
Rolipram |
Rolipram |
1件: D01783 D01783 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
008 2件: 8 , 13 💬 |
1711 |
Rpc-1063 |
- |
- |
- |
- |
013 1件: 13 💬 |
1712 |
Rpc1063 |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
1713 |
Rtl1000 (recombinant t cell receptor ligand) |
- |
- |
- |
- |
013 1件: 13 💬 |
1714 |
S-warfarin |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
013 1件: 13 💬 |
1715 |
Sa237 |
- |
- |
- |
- |
013 1件: 13 💬 |
1716 |
Saline |
- |
- |
- |
- |
006 10件: 6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
1717 |
Sar339658 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
1718 |
Sar442168 |
- |
- |
- |
- |
013 1件: 13 💬 |
1719 |
Sativex |
- |
- |
- |
- |
002 2件: 2 , 13 💬 |
1720 |
Sativex oromucosal spray |
- |
- |
- |
- |
013 1件: 13 💬 |
1721 |
Sativex oromucosal spray (non-marketed) |
- |
- |
- |
- |
013 1件: 13 💬 |
1722 |
Sativex® |
- |
- |
- |
- |
013 1件: 13 💬 |
1723 |
Satralizumab |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
1724 |
Satralizumab (120 mg/pfs with nsd) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
1725 |
Satralizumab (120 mg/vial) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
1726 |
Satralizumab (120mg/vial) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
1727 |
Satralizumab (r-inn) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
1728 |
Satralizumab (ro5333787/enspryng /sa237) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
1729 |
Satralizumab (ro5333787/enspryng/sa237) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
1730 |
Satralizumab (ro5333787/sa237) |
Satralizumab |
1件: D11079 D11079 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
1731 |
Satrazlizumab (ro5333787/ enspryng /sa237) |
- |
- |
- |
- |
013 1件: 13 💬 |
1732 |
Sb-683699 |
- |
- |
- |
- |
013 1件: 13 💬 |
1733 |
Sb683699 |
- |
- |
- |
- |
013 1件: 13 💬 |
1734 |
Sc interferon beta-1a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1735 |
Sc interferon beta-1b |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1736 |
Sc peginterferon beta-1a |
Peginterferon beta-1a |
1件: D10483 D10483 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1737 |
Sclerolym |
- |
- |
- |
- |
013 1件: 13 💬 |
1738 |
Scm |
- |
- |
- |
- |
013 1件: 13 💬 |
1739 |
Scm-010 |
- |
- |
- |
- |
013 1件: 13 💬 |
1740 |
Seasonal influenza vaccine |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
1741 |
Seasonal quadrivalent influenza vaccine |
- |
- |
- |
- |
013 1件: 13 💬 |
1742 |
Second-generation fumaric acid |
Fumaric Acid |
1件: D02308 D02308 💬 |
- |
- |
013 1件: 13 💬 |
1743 |
Secukinumab |
Secukinumab |
1件: D09967 D09967 💬 |
IL17A 1件: IL17A 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
013 7件: 13, 37, 41, 46, 160, 269, 271 💬 |
1744 |
See intervention description) |
- |
- |
- |
- |
013 1件: 13 💬 |
1745 |
Selenium |
Selenium |
- |
- |
- |
013 3件: 13, 278, 298 💬 |
1746 |
Sendoxan |
- |
- |
- |
- |
013 2件: 13, 43 💬 |
1747 |
Sendoxane |
- |
- |
- |
- |
013 1件: 13 💬 |
1748 |
Serum containing avonex |
- |
- |
- |
- |
013 1件: 13 💬 |
1749 |
Serum free avonex |
- |
- |
- |
- |
013 1件: 13 💬 |
1750 |
Sh u 555 c |
- |
- |
- |
- |
013 1件: 13 💬 |
1751 |
Silodyx |
- |
- |
- |
- |
013 1件: 13 💬 |
1752 |
Simethicone |
Simethicone |
1件: D05841 D05841 💬 |
- |
- |
013 2件: 13, 96 💬 |
1753 |
Simvahexal® 40 mg filmtabletten |
- |
- |
- |
- |
013 1件: 13 💬 |
1754 |
Simvastatin |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 21件: 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
1755 |
Simvastatin 40 mg film-coated tablets |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
1756 |
Simvastatin alternova |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
1757 |
Simvastatin in relapsing remitting multiple sclerosis |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
1758 |
Simvastatina |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
1759 |
Simvastatina sandoz 40 mg comprimidos recubiertos con película efg |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
1760 |
Simvastatine |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 3件: 6 , 13, 288 💬 |
1761 |
Simvastatine sandoz 40 mg filmomhulde tabletten |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
1762 |
Simvastatine sandoz 40mg deelbare filmomhulde tabletten |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
1763 |
Sinvastatina sandoz 40 mg comprimidos revestidos por película |
- |
- |
- |
- |
013 1件: 13 💬 |
1764 |
Siponimod |
Siponimod |
1件: D11460 D11460 💬 |
S1PR1 2件: S1PR1, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 2件: 13, 50 💬 |
1765 |
Siponimod 0.25 mg tablet |
Siponimod |
1件: D11460 D11460 💬 |
S1PR1 2件: S1PR1, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 2件: 13, 50 💬 |
1766 |
Siponimod 0.5 mg tablet |
Siponimod |
1件: D11460 D11460 💬 |
S1PR1 2件: S1PR1, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 2件: 13, 50 💬 |
1767 |
Siponimod 1 mg tablet |
Siponimod |
1件: D11460 D11460 💬 |
S1PR1 2件: S1PR1, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 2件: 13, 50 💬 |
1768 |
Siponimod 2 mg tablet |
Siponimod |
1件: D11460 D11460 💬 |
S1PR1 2件: S1PR1, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 2件: 13, 50 💬 |
1769 |
Sirolimus |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 35件: 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
1770 |
Sivatin |
- |
- |
- |
- |
013 1件: 13 💬 |
1771 |
Sivatin 40 mg film-coated tablets |
- |
- |
- |
- |
013 1件: 13 💬 |
1772 |
Sivelestat |
Sivelestat |
1件: D03788 D03788 💬 |
ELANE 1件: ELANE 💬 |
Neutrophil extracellular trap formation 3件: Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer |
013 3件: 13, 85, 96 💬 |
1773 |
Smderpept |
- |
- |
- |
- |
013 1件: 13 💬 |
1774 |
Smoked cannabis |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
1775 |
Sodium chlorid |
- |
- |
- |
- |
013 1件: 13 💬 |
1776 |
Sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 20件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
1777 |
Sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
011 3件: 11, 13, 228 💬 |
1778 |
Solifenacin |
Solifenacin |
2件: D01269 D01269, D08522 D08522 💬 |
CHRM3 1件: CHRM3 💬 |
Alzheimer disease 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
006 2件: 6 , 13 💬 |
1779 |
Solifenacin succinate |
Solifenacin |
2件: D01269 D01269, D08522 D08522 💬 |
CHRM3 1件: CHRM3 💬 |
Alzheimer disease 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
013 1件: 13 💬 |
1780 |
Soliris |
- |
- |
- |
- |
011 7件: 11, 13, 14, 61, 62, 109, 222 💬 |
1781 |
Solu medrol - 125 mg/2 ml polvere e solvente per soluzione iniettabile 1 flacone a doppia camera da 125 mg/2 ml |
- |
- |
- |
- |
013 3件: 13, 14, 53 💬 |
1782 |
Solu-medrol |
- |
- |
- |
- |
013 7件: 13, 49, 50, 51, 53, 97, 211 💬 |
1783 |
Solu-moderin 1 g |
- |
- |
- |
- |
013 1件: 13 💬 |
1784 |
Solumedrol |
- |
- |
- |
- |
013 1件: 13 💬 |
1785 |
Solumedrol im 125mg/2ml |
- |
- |
- |
- |
013 1件: 13 💬 |
1786 |
Somatorelin |
Somatorelin |
1件: D08523 D08523 💬 |
GHRHR 1件: GHRHR 💬 |
Growth hormone synthesis, secretion and action 2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
013 2件: 13, 78 💬 |
1787 |
Sparc0921 |
- |
- |
- |
- |
013 1件: 13 💬 |
1788 |
Spiropent |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
1789 |
Sr-fampridine |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
1790 |
Ss-interferon |
- |
- |
- |
- |
013 1件: 13 💬 |
1791 |
Standard gadolinium contrast |
Gadolinium |
- |
- |
- |
013 1件: 13 💬 |
1792 |
Standard interval dosing |
- |
- |
- |
- |
013 1件: 13 💬 |
1793 |
Standard ms dmt |
- |
- |
- |
- |
013 1件: 13 💬 |
1794 |
Standard ms dmts |
- |
- |
- |
- |
013 1件: 13 💬 |
1795 |
Standard of care |
- |
- |
- |
- |
006 12件: 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
1796 |
Standard treatment with a conventional drug |
- |
- |
- |
- |
013 1件: 13 💬 |
1797 |
Standardized cannabis extract |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
1798 |
Statin |
- |
- |
- |
- |
013 1件: 13 💬 |
1799 |
Stem cell transplantation |
- |
- |
- |
- |
013 10件: 13, 19, 20, 46, 65, 90, 125, 164, 234, 326 💬 |
1800 |
Study drug |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
1801 |
Sub0750mig |
- |
- |
- |
- |
013 1件: 13 💬 |
1802 |
Sub175614 |
- |
- |
- |
- |
013 1件: 13 💬 |
1803 |
Sub22282 |
- |
- |
- |
- |
013 1件: 13 💬 |
1804 |
Sublingual tizanidine 12 mg |
Tizanidine |
2件: D00776 D00776, D08611 D08611 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
1805 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 25件: 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
1806 |
Sunphenon |
- |
- |
- |
- |
013 2件: 13, 113 💬 |
1807 |
Sunphenon egcg |
Epigallocatechin gallate |
- |
- |
- |
013 3件: 13, 17, 113 💬 |
1808 |
Sunphenon egcg tm |
- |
- |
- |
- |
013 1件: 13 💬 |
1809 |
Suspension media |
- |
- |
- |
- |
013 1件: 13 💬 |
1810 |
Sustained-release oral dalfampridine |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
1811 |
Suvorexant |
Suvorexant |
1件: D10082 D10082 💬 |
HCRTR1 2件: HCRTR1, HCRTR2 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
005 3件: 5 , 6 , 13 💬 |
1812 |
T cell vaccination |
- |
- |
- |
- |
013 1件: 13 💬 |
1813 |
T-cell vaccination |
- |
- |
- |
- |
013 1件: 13 💬 |
1814 |
Tachipirina |
- |
- |
- |
- |
013 2件: 13, 53 💬 |
1815 |
Tachipirina - 500 mg compresse20 compresse |
- |
- |
- |
- |
013 2件: 13, 53 💬 |
1816 |
Taci-fc5 |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 3件: 13, 46, 49 💬 |
1817 |
Tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
1818 |
Tanakan |
Ginkgo biloba |
- |
- |
- |
013 1件: 13 💬 |
1819 |
Tarenflurbil |
Tarenflurbil |
1件: D09010 D09010 💬 |
APH1A 4件: APH1A, NCSTN, PSEN1, PSENEN 💬 |
Alzheimer disease 6件: Alzheimer disease, Human papillomavirus infection, Neurotrophin signaling pathway, Notch signaling pathway, Pathways of neurodegeneration - multiple diseases, Wnt signaling pathway |
013 1件: 13 💬 |
1820 |
Targretin |
- |
- |
- |
- |
013 1件: 13 💬 |
1821 |
Taurine |
Taurine |
1件: D00047 D00047 💬 |
- |
- |
013 1件: 13 💬 |
1822 |
Tauroursodeoxycholic acid |
Tauroursodeoxycholic acid |
1件: D11836 D11836 💬 |
- |
- |
002 4件: 2 , 13, 93, 299 💬 |
1823 |
Tcelna |
- |
- |
- |
- |
013 1件: 13 💬 |
1824 |
Tecfidera |
- |
- |
- |
- |
013 1件: 13 💬 |
1825 |
Tecfidera (bg00012) |
- |
- |
- |
- |
013 1件: 13 💬 |
1826 |
Tecfidera (bg12) |
- |
- |
- |
- |
013 1件: 13 💬 |
1827 |
Tecfidera® |
- |
- |
- |
- |
013 1件: 13 💬 |
1828 |
Tecfidera® 120 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1829 |
Tecfidera® 120mg magensaftresistente hartkapseln |
- |
- |
- |
- |
013 1件: 13 💬 |
1830 |
Tecfidera® 240 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1831 |
Tecfidera® 240mg magensaftresistente hartkapseln |
- |
- |
- |
- |
013 1件: 13 💬 |
1832 |
Tecifdera (dimethyl fumarate) |
Dimethyl fumarate |
1件: D03846 D03846 💬 |
KEAP1 1件: KEAP1 💬 |
Fluid shear stress and atherosclerosis 4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 1件: 13 💬 |
1833 |
Temelimab |
Temelimab |
- |
- |
- |
013 1件: 13 💬 |
1834 |
Temelimab 18 mg/kg |
Temelimab |
- |
- |
- |
013 1件: 13 💬 |
1835 |
Temelimab 36 mg/kg |
Temelimab |
- |
- |
- |
013 1件: 13 💬 |
1836 |
Temelimab 54 mg/kg |
Temelimab |
- |
- |
- |
013 1件: 13 💬 |
1837 |
Temsirolimus |
Temsirolimus |
1件: D06068 D06068 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
013 4件: 13, 34, 89, 331 💬 |
1838 |
Temsirolimus tablets |
Temsirolimus |
1件: D06068 D06068 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
013 1件: 13 💬 |
1839 |
Teriflunomide |
Teriflunomide |
1件: D10172 D10172 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 2件: 13, 25 💬 |
1840 |
Teriflunomide (hmr1726) |
Teriflunomide |
1件: D10172 D10172 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 1件: 13 💬 |
1841 |
Teriflunomide 14 mg |
Teriflunomide |
1件: D10172 D10172 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 1件: 13 💬 |
1842 |
Teriflunomide 14 mg oral tablet [aubagio] |
Teriflunomide |
1件: D10172 D10172 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 1件: 13 💬 |
1843 |
Teriflunomide capsule |
Teriflunomide |
1件: D10172 D10172 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 1件: 13 💬 |
1844 |
Teriflunomide hmr1726 |
Teriflunomide |
1件: D10172 D10172 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 1件: 13 💬 |
1845 |
Testosterone |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
001 8件: 1 , 2 , 3 , 13, 60, 78, 113, 265 💬 |
1846 |
Testosterone undecanoate |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
013 2件: 13, 60 💬 |
1847 |
Tetanus diphtheria toxoid vaccine (td) |
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
013 1件: 13 💬 |
1848 |
Tetanus diphtheria toxoids vaccine |
- |
- |
- |
- |
013 1件: 13 💬 |
1849 |
Tetanus toxoid |
Clostridium tetani toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
013 2件: 13, 46 💬 |
1850 |
Tetanus toxoid (tt) containing vaccine (td, tdap) |
Clostridium tetani toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
013 1件: 13 💬 |
1851 |
Tetanus toxoid vaccine |
Clostridium tetani toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
013 1件: 13 💬 |
1852 |
Tetracycline |
Tetracycline |
1件: D00201 D00201 💬 |
- |
- |
013 4件: 13, 46, 53, 97 💬 |
1853 |
Tetracycline - statin - antimycotic |
Tetracycline |
1件: D00201 D00201 💬 |
- |
- |
013 1件: 13 💬 |
1854 |
Tetrahydrocannabinol |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 3件: 8 , 13, 298 💬 |
1855 |
Tetrahydrocannabinol botanical drug substance (thc bds) |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
1856 |
Tg |
- |
- |
- |
- |
013 2件: 13, 37 💬 |
1857 |
Tg-1101 |
- |
- |
- |
- |
013 1件: 13 💬 |
1858 |
Thc |
- |
- |
- |
- |
008 4件: 8 , 13, 46, 96 💬 |
1859 |
Thiamine |
Thiamine |
1件: D08580 D08580 💬 |
- |
- |
008 3件: 8 , 13, 265 💬 |
1860 |
Thioplex |
- |
- |
- |
- |
013 1件: 13 💬 |
1861 |
Thiotepa |
Thiotepa |
1件: D00583 D00583 💬 |
- |
- |
013 11件: 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284 💬 |
1862 |
Thymoglobuline |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 5件: 13, 36, 51, 60, 96 💬 |
1863 |
Thymoglobuline® |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 1件: 13 💬 |
1864 |
Tissue selective estrogen complex |
- |
- |
- |
- |
013 1件: 13 💬 |
1865 |
Tizanidine |
Tizanidine |
2件: D00776 D00776, D08611 D08611 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
1866 |
Tizanidine (sublingual or oral) |
Tizanidine |
2件: D00776 D00776, D08611 D08611 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
1867 |
Tizanidine hydrochloride capsule |
Tizanidine |
2件: D00776 D00776, D08611 D08611 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
1868 |
Tmp001 |
- |
- |
- |
- |
013 1件: 13 💬 |
1869 |
Tocilizumab |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
1870 |
Tocilizumab injection |
Tocilizumab |
1件: D02596 D02596 💬 |
IL6R 1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
1871 |
Tocopherol |
Tocopherol |
1件: D02332 D02332 💬 |
- |
- |
013 5件: 13, 49, 206, 257, 298 💬 |
1872 |
Tolerogenic dendritic cells (toldc) |
- |
- |
- |
- |
013 1件: 13 💬 |
1873 |
Tolerogenic dendritic cells loaded with myelin peptides |
- |
- |
- |
- |
013 1件: 13 💬 |
1874 |
Tolperisone |
Tolperisone |
1件: D08617 D08617 💬 |
- |
- |
013 1件: 13 💬 |
1875 |
Tolperisone hc1 |
Tolperisone |
1件: D08617 D08617 💬 |
- |
- |
013 1件: 13 💬 |
1876 |
Tolperisone hcl |
Tolperisone |
1件: D08617 D08617 💬 |
- |
- |
013 1件: 13 💬 |
1877 |
Tolpersan |
- |
- |
- |
- |
013 1件: 13 💬 |
1878 |
Tolposan |
- |
- |
- |
- |
013 1件: 13 💬 |
1879 |
Topical preparation h arm |
- |
- |
- |
- |
013 1件: 13 💬 |
1880 |
Torvast |
- |
- |
- |
- |
013 1件: 13 💬 |
1881 |
Torvast*10cpr 10mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1882 |
Tovaxin |
- |
- |
- |
- |
013 1件: 13 💬 |
1883 |
Tovaxin autologous t cell vaccine |
- |
- |
- |
- |
013 1件: 13 💬 |
1884 |
Tracleer |
- |
- |
- |
- |
013 8件: 13, 51, 84, 85, 86, 88, 210, 211 💬 |
1885 |
Trancopal |
- |
- |
- |
- |
013 1件: 13 💬 |
1886 |
Trancopal dolo |
- |
- |
- |
- |
013 1件: 13 💬 |
1887 |
Treosulfan |
Treosulfan |
1件: D07253 D07253 💬 |
- |
- |
013 3件: 13, 19, 65 💬 |
1888 |
Trichuris suis eggs |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
1889 |
Trichuris suis ova |
- |
- |
- |
- |
013 4件: 13, 46, 96, 97 💬 |
1890 |
Trichuris suis ova (eggs), embryonated, viable |
- |
- |
- |
- |
013 1件: 13 💬 |
1891 |
Trileptal |
- |
- |
- |
- |
013 1件: 13 💬 |
1892 |
Triomar™ (omega-3 fatty acids) |
Omega-3 fatty acids |
- |
- |
- |
013 1件: 13 💬 |
1893 |
Trivalent seasonal influenza vaccine |
- |
- |
- |
- |
013 1件: 13 💬 |
1894 |
Tro19622 |
TRO19622 |
- |
- |
- |
002 3件: 2 , 3 , 13 💬 |
1895 |
Trulicity |
- |
- |
- |
- |
013 1件: 13 💬 |
1896 |
Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere |
- |
- |
- |
- |
013 1件: 13 💬 |
1897 |
Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere. |
- |
- |
- |
- |
013 1件: 13 💬 |
1898 |
Tso |
- |
- |
- |
- |
013 3件: 13, 46, 97 💬 |
1899 |
Tt vaccine |
- |
- |
- |
- |
013 1件: 13 💬 |
1900 |
Tv-5010 |
- |
- |
- |
- |
013 1件: 13 💬 |
1901 |
Tv-5600 |
- |
- |
- |
- |
008 3件: 8 , 13, 96 💬 |
1902 |
Tylenol pill |
- |
- |
- |
- |
013 1件: 13 💬 |
1903 |
Tysabri |
- |
- |
- |
- |
013 3件: 13, 25, 63 💬 |
1904 |
Tysabri 300 mg concentrado para solución para perfusión |
- |
- |
- |
- |
013 1件: 13 💬 |
1905 |
Tysabri 300 mg concentrate for solution for infusion |
- |
- |
- |
- |
013 1件: 13 💬 |
1906 |
Tysabri 300 mg solution à diluer pour perfusion |
- |
- |
- |
- |
013 1件: 13 💬 |
1907 |
Tysabri and avonex |
- |
- |
- |
- |
013 1件: 13 💬 |
1908 |
Tysabri ® (natalizumab) |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
1909 |
Tysabri*iv 1fl 300mg 15ml |
- |
- |
- |
- |
013 1件: 13 💬 |
1910 |
Tysabri® |
- |
- |
- |
- |
013 1件: 13 💬 |
1911 |
Tysabri® (natalizumab) |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
1912 |
Ublituximab |
Ublituximab |
1件: D11243 D11243 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
1913 |
Ubltuximab |
- |
- |
- |
- |
013 1件: 13 💬 |
1914 |
Ucb l059 |
- |
- |
- |
- |
013 1件: 13 💬 |
1915 |
Uk: sativex oromucosal spray |
- |
- |
- |
- |
013 1件: 13 💬 |
1916 |
Ultomiris |
- |
- |
- |
- |
002 4件: 2 , 11, 13, 62 💬 |
1917 |
Ultra small particles of iron oxide (uspio) |
Ferric oxide |
1件: D04168 D04168 💬 |
- |
- |
013 1件: 13 💬 |
1918 |
Ultrasmall particles of iron oxide |
Ferric oxide |
1件: D04168 D04168 💬 |
- |
- |
013 1件: 13 💬 |
1919 |
Umbilical cord derived mesenchymal stem cells |
- |
- |
- |
- |
013 1件: 13 💬 |
1920 |
Umbilical cord mesenchymal stem cells |
- |
- |
- |
- |
013 5件: 13, 46, 57, 97, 113 💬 |
1921 |
Undifferentiated autologous mesenchymal stem cells |
- |
- |
- |
- |
013 1件: 13 💬 |
1922 |
Untreated to atorvastatin treatment |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
1923 |
Urbason |
- |
- |
- |
- |
013 3件: 13, 97, 222 💬 |
1924 |
Urbason 40 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1925 |
Urbason 40 mg comprimidos |
- |
- |
- |
- |
013 1件: 13 💬 |
1926 |
Urbason forte |
- |
- |
- |
- |
013 1件: 13 💬 |
1927 |
Urbason solubile forte 1000mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1928 |
Urbason® solubile forte 1000 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1929 |
Urine samples |
- |
- |
- |
- |
013 1件: 13 💬 |
1930 |
Uvedose 100 000 ui |
- |
- |
- |
- |
013 1件: 13 💬 |
1931 |
Uvedose 100 000 ui, solution buvable en ampoule |
- |
- |
- |
- |
013 1件: 13 💬 |
1932 |
V08ca02 |
- |
- |
- |
- |
013 1件: 13 💬 |
1933 |
V08ca09 |
- |
- |
- |
- |
013 1件: 13 💬 |
1934 |
Vaginal estriol |
Estriol |
2件: D00185 D00185, D01986 D01986 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 1件: 13 💬 |
1935 |
Vardenafil |
Vardenafil |
3件: D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
013 3件: 13, 86, 299 💬 |
1936 |
Vardenafil (hidrocloride) |
Vardenafil |
3件: D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
1937 |
Vardenafilo |
Vardenafil |
3件: D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
1938 |
Vardenafilo hidrocloruro |
Vardenafil |
3件: D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
1939 |
Vatelizumab |
Vatelizumab |
- |
- |
- |
013 2件: 13, 97 💬 |
1940 |
Vay736 |
- |
- |
- |
- |
013 7件: 13, 35, 46, 49, 53, 85, 95 💬 |
1941 |
Vb13s1 |
- |
- |
- |
- |
013 1件: 13 💬 |
1942 |
Vb5s2 |
- |
- |
- |
- |
013 1件: 13 💬 |
1943 |
Vb6s5 |
- |
- |
- |
- |
013 1件: 13 💬 |
1944 |
Vehicle gel |
- |
- |
- |
- |
013 2件: 13, 34 💬 |
1945 |
Venlafaxin hexal |
- |
- |
- |
- |
013 1件: 13 💬 |
1946 |
Venlafaxine |
Venlafaxine |
2件: D00821 D00821, D08670 D08670 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 3件: 6 , 13, 46 💬 |
1947 |
Venlafaxine hydrochloride |
Venlafaxine |
2件: D00821 D00821, D08670 D08670 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
013 2件: 13, 46 💬 |
1948 |
Verum arm receiving gilenya® |
- |
- |
- |
- |
013 1件: 13 💬 |
1949 |
Verum arm receiving vitamin d oil |
Vitamin D |
- |
- |
- |
013 1件: 13 💬 |
1950 |
Vessel |
- |
- |
- |
- |
013 4件: 13, 51, 271, 288 💬 |
1951 |
Vidofludimus |
Vidofludimus |
- |
- |
- |
013 5件: 13, 46, 94, 96, 97 💬 |
1952 |
Vidofludimus calcium |
Calcium |
- |
- |
- |
013 4件: 13, 94, 96, 97 💬 |
1953 |
Vigantol |
- |
- |
- |
- |
013 4件: 13, 65, 96, 97 💬 |
1954 |
Vigantol oel |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
1955 |
Vigantol oil |
- |
- |
- |
- |
013 1件: 13 💬 |
1956 |
Vigantol oil plus interferon beta-1a (rebif) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
1957 |
Vigantol® oil |
- |
- |
- |
- |
013 1件: 13 💬 |
1958 |
Vigantol® öl 20.000 i.e./ml |
- |
- |
- |
- |
013 1件: 13 💬 |
1959 |
Vitamin a |
Vitamin A |
2件: D00069 D00069, D06543 D06543 💬 |
RARA 2件: RARA, RARB 💬 |
Acute myeloid leukemia 8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer |
013 3件: 13, 53, 90 💬 |
1960 |
Vitamin d |
Vitamin D |
- |
- |
- |
013 21件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
1961 |
Vitamin d3 |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 11件: 6 , 13, 20, 46, 49, 53, 60, 65, 96, 97, 299 💬 |
1962 |
Vitamin e |
Vitamin E |
1件: D02331 D02331 💬 |
- |
- |
002 11件: 2 , 6 , 13, 20, 46, 90, 96, 97, 206, 299, 317 💬 |
1963 |
Vitamin e/selenium |
Selenium |
1件: D02331 D02331 💬 |
- |
- |
013 1件: 13 💬 |
1964 |
Vitamin k |
Phylloquinone |
1件: D00148 D00148 💬 |
- |
- |
013 5件: 13, 46, 96, 97, 299 💬 |
1965 |
Vitamina d3 kern pharma solución oleosa |
- |
- |
- |
- |
013 1件: 13 💬 |
1966 |
Vsn16r |
- |
- |
- |
- |
013 1件: 13 💬 |
1967 |
Vsn16r 100mg |
- |
- |
- |
- |
013 1件: 13 💬 |
1968 |
Vx15/2503 |
- |
- |
- |
- |
008 2件: 8 , 13 💬 |
1969 |
Warfarin |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
1970 |
Water |
Water |
1件: D00001 D00001 💬 |
- |
- |
002 22件: 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
1971 |
Way-130799 |
- |
- |
- |
- |
013 1件: 13 💬 |
1972 |
Xbd173 |
- |
- |
- |
- |
013 1件: 13 💬 |
1973 |
Xcel-mc-alpha |
- |
- |
- |
- |
013 1件: 13 💬 |
1974 |
Xeomin |
- |
- |
- |
- |
005 7件: 5 , 6 , 7 , 13, 15, 17, 113 💬 |
1975 |
Xyosted |
- |
- |
- |
- |
013 1件: 13 💬 |
1976 |
Xyosted 75 milligram (mg) in 0.5 ml auto-injector |
- |
- |
- |
- |
013 1件: 13 💬 |
1977 |
Zenapax |
- |
- |
- |
- |
013 1件: 13 💬 |
1978 |
Zinbryta |
- |
- |
- |
- |
013 1件: 13 💬 |
1979 |
Zk 157046 |
- |
- |
- |
- |
013 1件: 13 💬 |
1980 |
Zol446h |
- |
- |
- |
- |
013 1件: 13 💬 |
1981 |
Zoledronic acid |
Zoledronic acid |
4件: D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
006 9件: 6 , 13, 46, 93, 95, 96, 274, 299, 333 💬 |
1982 |
Zoledronic acid monohydrate |
Zoledronic acid |
4件: D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |